Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 109.7;Enterocytes: 113.2;Late spermatids: 127.1;Paneth cells: 73.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.5;HUVEC TERT2: 35.9;RPMI-8226: 13.5;TIME: 19.4;U-138 MG: 12.9;U-266/84: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.7	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.5	0.3	1.6	0.8	0.0	0.7	0.3	1.1	0.7	0.0	4.8	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.9	3.6	10.5	7.5	35.9	0.2	8.6	0.0	1.2	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.1	13.5	0.7	0.1	0.0	0.1	0.6	0.0	0.3	1.3	0.0	0.3	19.4	12.9	0.9	0.3	1.0	0.5	15.2	0.0	2.7	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1	0.0	1.4	1.5	0.2	4.5	0.0	0.0	0.0	0.0	3.4	5.2	0.0	0.1	44.7	0.7	109.7	0.1	113.2	23.3	2.2	0.1	1.0	0.5	5.7	0.0	8.9	0.0	5.2	0.0	0.3	127.1	1.7	1.3	1.7	47.7	36.6	0.0	5.0	73.7	0.7	0.0	0.0	0.0	1.0	1.5	0.8	5.0	0.1	5.7	46.8	0.4
ANKRD30A	NY-BR-1	ENSG00000148513	"Ankyrin repeat domain 30A"	Q9BXX3	10	37125788-37384111	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"breast: 31.7;testis: 17.8"	"Cell type enhanced"	"Detected in some"	27	"Early spermatids: 12.3;Late spermatids: 4.8;Spermatocytes: 23.6"	"Cancer enriched"	"Detected in single"	37	"breast cancer: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	33	"A549: 3.9;U-266/70: 15.6"									HPA071849			Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA071849: "	"unprognostic (2.79e-1)"											"unprognostic (2.81e-1)"	"unprognostic (1.01e-7)"	"unprognostic (1.41e-1)"		"unprognostic (5.93e-1)"		0.6	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	23.6	1.7	0.0	0.2	0.0	0.0	0.0
ANKRD30B	NY-BR-1.1	ENSG00000180777	"Ankyrin repeat domain 30B"	Q9BXX2	18	14728272-14852738	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	17	"testis: 42.2"	"Group enriched"	"Detected in some"	8	"Early spermatids: 10.7;Late spermatids: 11.2;Spermatocytes: 17.0"	"Cancer enhanced"	"Detected in single"		"breast cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2197: 31.8"									"HPA060455, HPA071849"	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA060455: AB_2684282, HPA071849: "	"unprognostic (1.53e-1)"		"unprognostic (1.50e-1)"		"unprognostic (1.01e-2)"				"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-9)"	"unprognostic (1.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.98e-2)"		0.3	0.2	1.2	0.1	2.5	0.1	2.3	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	0.9	0.1	0.1	0.1	0.1	0.4	1.2	0.1	0.6	0.1	0.0	0.1	1.0	0.1	0.2	2.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	42.2	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.8	2.6	0.1	31.8	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.5	0.0	1.8	0.9	0.9	0.4	1.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	10.7	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.8	11.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.4	0.3	0.5	0.0	0.6	0.1
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 101.7;Syncytiotrophoblasts: 132.0;Urothelial cells: 125.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Cell line enhanced"	"Detected in many"		"GAMG: 30.4;HBEC3-KT: 25.2;hTCEpi: 30.7"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in all"			HPA017292	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavorable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.1	1.5	8.7	5.3	7.3	21.6	7.9	0.2	0.4	1.7	1.4	3.2	8.5	0.0	1.0	0.0	30.4	7.4	8.9	25.2	1.4	0.0	5.5	0.8	0.7	0.0	9.3	8.1	4.0	10.1	30.7	1.3	23.0	2.3	15.7	0.0	9.2	0.0	13.8	0.0	0.0	2.6	3.6	9.5	14.0	2.5	4.4	0.0	5.3	4.5	0.4	8.3	4.5	0.0	1.9	4.1	0.0	9.9	23.1	0.4	3.4	0.5	3.9	0.0	0.0	0.0	3.3	19.2	8.6	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3	6.0	17.4	0.0	55.5	57.9	7.1	2.0	12.7	101.7	27.3	5.2	21.6	24.4	1.7	15.7	9.9	10.0	77.7	0.0	10.5	9.4	7.4	42.6	13.9	0.4	25.3	3.2	36.7	3.1	9.7	19.2	1.4	50.1	11.8	11.8	73.1	3.2	25.3	42.1	0.4	4.3	12.7	0.0	3.4	0.9	0.4	74.2	132.0	0.7	26.9	125.2
BAHCC1	"BAHD2, KIAA1447"	ENSG00000266074	"BAH domain and coiled-coil containing 1"		17	81395475-81466332	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 22.2"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 47.8;Cone photoreceptor cells: 21.6;Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.4;plasmacytoid DC: 1.1"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.1;granulocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 11.0;MOLT-4: 13.6;NB-4: 46.8;REH: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023386, HPA076910"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA023386: AB_1859537, HPA076910: AB_2732325"	"unprognostic (2.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (7.38e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.78e-2)"	5.9	4.8	5.0	3.0	8.3	8.1	3.6	22.2	7.4	5.1	3.1	10.6	1.1	6.0	4.5	2.3	2.5	3.8	5.6	2.2	4.8		2.8	1.1	4.4	1.1	8.5	5.7	6.0	4.3	5.3	3.2	1.6	4.9	4.4	1.5	9.5	6.1	3.8	6.2	4.4	5.5	4.0	3.2	4.9	3.6	4.4	10.4	9.6	2.5	1.6	0.5	3.7	4.4	0.0	1.1	1.4	0.1	0.0	0.0	0.0	1.7	3.0	2.2	7.3	0.8	1.2	1.0	1.3	1.1	0.7	0.4	0.5	0.8	0.0	2.0	1.5	1.0	1.8	1.0	0.8	0.1	0.0	3.3	2.4	0.7	0.9	0.7	11.0	2.3	2.0	0.3	0.6	0.6	1.1	0.8	2.8	1.7	0.0	0.3	1.0	13.6	46.8	0.1	1.1	2.0	14.3	1.5	0.0	0.9	0.1	10.2	1.6	1.6	0.0	5.8	0.2	0.3	8.8	1.0	4.0	0.5	2.1	0.6	0.0	0.0	0.0	0.0	5.1	0.7	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0											6.0	9.6	0.0	1.4	0.0	47.8	5.8	15.3	4.0	6.8	3.5	21.6	0.1	1.7	2.8	0.5	4.7	3.2	0.0	3.7	0.1	4.3	1.3	0.0	3.0	0.5	31.8	8.1	4.9	5.1	0.0	6.9	1.3	0.0	1.0	4.2	7.5	1.6	0.0	5.3	0.8	16.8	0.0	2.0	1.5	7.8	0.0	0.0	0.0	4.5	0.7
BATF2	MGC20410	ENSG00000168062	"Basic leucine zipper ATF-like transcription factor 2"	Q8N1L9	11	64987943-64997045	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 8.4;Mucus-secreting cells: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 6.6;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 9.6;monocytes: 6.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 11.4;BJ hTERT+ SV40 Large T+ RasG12V: 17.5;GAMG: 15.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062496	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA062496: AB_2684783"	"unprognostic (5.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.08e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (9.39e-5)"	"prognostic unfavorable (2.12e-4)"	"unprognostic (1.28e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.17e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.12e-2)"	2.8	5.3	2.4	8.3	3.3	0.4	3.2	1.0	3.4	2.0	8.9	1.9	7.2	8.8	2.1	2.8	2.3	2.9	9.3	2.2	1.9	1.7	10.0	5.4	7.8	2.7	2.2	2.4	3.2	17.3	0.7	3.1	3.0	5.9	7.9	6.7	4.2	14.0	5.1	4.8	0.5	14.0	2.7	2.1	18.7	5.1	0.9	1.7	0.9	16.5	1.0	3.4	3.9	1.2	1.3	0.3	9.6	6.6	0.1	0.1	0.9	1.2	0.8	0.1	0.0	0.1	0.5	0.0	0.4	5.4	11.4	17.5	1.5	4.7	0.0	2.2	0.7	15.6	0.1	0.0	1.3	0.8	0.1	0.3	1.6	0.0	3.9	4.3	0.0	1.0	0.3	0.4	1.5	1.9	0.4	2.7	0.1	3.4	0.1	0.2	0.3	0.0	0.1	0.3	0.0	0.5	0.0	1.1	0.4	1.4	0.1	0.1	0.0	0.4	0.3	5.4	0.1	0.5	0.8	2.0	0.6	0.6	1.0	0.0	0.0	0.1	0.4	0.9	0.5	0.5	0.0	2.6	1.1	0.0	6.6	0.0	1.3	0.0	0.1	0.3	0.4	0.0	0.0	9.6	0.1	3.1	0.0	0.0	0.9	2.4	3.3	1.0	3.4	1.9	1.7	2.2	2.4	5.9	1.7	3.0	1.3	3.7	0.6	0.0	0.0	0.5	5.1	4.0	2.3	1.8	0.0	0.0	1.7	4.6	0.9	1.5	8.4	0.0	5.8	0.2	0.9	0.2	0.0	0.8	3.8	0.0	2.4	5.5	2.7	1.7	0.0	1.0	0.0	1.0	8.0	0.8	4.6	7.0	0.7	3.3	0.1	0.0	1.5	0.1	0.6	0.0	0.0	0.0	6.3	1.1
BCAS3	FLJ20128	ENSG00000141376	"BCAS3, microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Late spermatids: 203.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA052409: AB_2681821, HPA057289: AB_2683399"	"unprognostic (2.84e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17.0	8.4	13.6	16.3	10.8	11.7	20.2	20.0	16.6	13.7	7.6	13.9	17.0	11.9	9.1	6.9	26.8	8.0	11.7	12.9	6.4	3.3	8.2	4.2	14.1	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6.0	5.9	5.0	2.6	2.4	2.9	4.7	3.0	9.4	3.2	4.6	5.0	4.8	1.6	2.8	8.6	3.4	3.0	5.5	7.2	4.2	5.1	2.7	6.6	3.2	43.3	4.6	1.2	4.4	16.2	9.3	5.7	5.7	6.0	3.0	12.7	6.3	5.3	7.1	2.1	5.0	14.8	7.7	2.4	3.9	4.8	4.1	2.0	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8.0	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20.0	6.0	12.2	2.7	7.8	4.5	13.0	11.2	5.1	48.2	12.5	15.7	9.8	5.9	8.3	3.6	38.8	8.5	3.6	0.0	3.1	4.3	5.0	3.6	16.1	8.6	3.7	3.2	6.9	12.9	5.6	203.3	6.9	4.7	1.7	7.2	4.6	30.3	3.2	4.8	19.8	23.0	13.4	12.9	14.4	11.1	4.7	4.8	6.3	11.8	2.6	6.9
BLCAP	BC10	ENSG00000166619	"Bladder cancer associated protein"	P62952	20	37492472-37527931	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 102.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 72.5"	"Low region specificity"	"Detected in all"							HPA047390			Approved	Nucleoli		NA	NA			Nucleoli		"HPA047390: AB_2680025"	"unprognostic (1.05e-2)"	"unprognostic (7.91e-3)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.91e-3)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (7.28e-5)"	18.9	16.7	31.6	12.9	89.5	10.7	16.4	23.2	40.1	14.3	15.6	13.3	11.4	17.6	9.8	19.9	18.5	50.5	17.9	23.5	26.5	44.4	21.3	23.8	12.2	12.5	22.5	28.3	15.1	7.9	15.4	34.4	26.1	27.6	18.9	18.8	13.4	17.7	21.1	102.5	30.3	18.9	13.4	13.4	14.2	12.4	12.2	10.6	8.5	14.0	27.3	17.8	20.2	12.7	48.0	20.5	26.6	22.2	17.0	28.4	18.7	27.0	8.0	9.4	9.7	18.2	14.0	13.3	13.0	12.6	11.6	9.5	27.8	22.1	14.1	13.0	18.0	11.1	52.5	7.0	53.9	12.1	2.9	6.3	4.6	17.8	25.7	11.7	9.1	6.1	17.8	58.1	11.1	21.1	9.6	16.1	10.3	4.4	10.6	23.3	15.2	7.5	7.2	7.5	15.3	22.5	7.2	35.1	9.4	13.3	72.5	8.6	10.4	15.6	45.3	10.5	10.1	14.9	8.7	15.3	30.1	7.7	10.5	5.5	5.8	7.2	6.8	12.5	8.4	5.3	26.6	22.2	25.9	18.7	21.5	20.4	37.5	21.4	19.8	20.5	48.0	28.4	22.0	23.2	17.0	19.3	8.8	20.6	18.7	31.6	89.5	23.2	40.1	26.5	44.4	22.5	28.3	27.6	10.6	74.5	32.3	42.7	79.2	130.6	42.3	49.4	35.7	64.3	67.1	38.4	21.6	98.9	69.6	30.6	58.8	43.9	49.9	0.0	29.8	68.6	31.1	44.2	29.9	70.6	48.4	39.7	39.3	74.3	36.4	108.7	27.6	35.6	33.7	16.2	50.0	37.9	37.4	28.1	55.9	41.1	33.0	32.3	28.8	23.1	23.8	107.4	54.3	33.2	29.7	128.8
BRF2	"BRFU, FLJ11052, TFIIIB50"	ENSG00000104221	"BRF2, RNA polymerase III transcription initiation factor subunit"	Q9HAW0	8	37843268-37849904	"Predicted intracellular proteins"	"Stress response, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019269, HPA023378"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"CAB019269: , HPA023378: AB_1845446"	"unprognostic (9.85e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.35e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.41e-2)"	12.6	10.3	8.4	8.3	9.9	19.0	12.1	9.8	17.9	12.8	11.0	8.7	9.7	7.5	14.7	10.4	9.2	12.9	8.6	17.0	9.9	8.6	8.7	8.8	9.0	11.6	10.2	10.7	20.2	16.2	8.4	11.1	12.9	9.5	14.8	8.5	11.4	10.6	13.3	32.4	11.9	8.1	12.4	7.4	11.0	9.5	13.1	9.9	21.7	10.7	10.7	9.0	11.5	19.0	12.8	8.3	10.2	8.8	16.6	19.1	10.2	9.8	7.6	7.5	10.0	10.4	7.7	8.8	11.8	9.2	15.7	10.8	9.8	7.1	12.0	17.3	7.3	6.3	10.3	9.6	7.3	7.8	7.6	9.8	14.9	6.4	8.0	10.9	5.9	9.0	10.2	9.6	15.7	6.7	8.1	5.1	11.1	18.2	10.8	5.0	5.8	18.6	8.5	12.9	7.2	9.7	11.6	8.7	6.2	5.7	6.6	6.4	8.5	5.6	8.2	13.2	11.3	17.2	13.0	6.8	8.5	11.3	18.2	12.0	13.5	18.1	14.2	11.6	9.1	14.8	10.2	8.8	9.5	12.7	7.8	12.7	12.7	13.3	12.9	6.9	12.8	19.1	15.3	3.6	16.6	7.2	8.3	11.5	10.2	8.4	9.9	9.8	17.9	9.9	8.6	10.2	10.7	9.5	9.9	11.9	4.5	1.5	3.7	3.9	8.9	0.3	5.1	5.3	2.3	8.7	0.0	18.8	6.6	7.4	0.3	5.6	7.7	46.7	9.7	8.6	7.1	2.8	2.3	1.7	10.0	7.9	6.3	4.9	7.8	1.6	8.6	3.5	3.3	9.0	7.1	11.4	5.0	0.0	9.9	4.0	6.8	6.5	6.6	10.0	10.5	3.3	11.8	8.7	6.2	2.1
CCDC149	DKFZp761B107	ENSG00000181982	"Coiled-coil domain containing 149"	Q6ZUS6	4	24806117-24980204	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 4.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 21.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044158, HPA047913"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA044158: AB_2678840, HPA047913: AB_2680207"	"unprognostic (1.68e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.09e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.11e-4)"	"unprognostic (9.71e-5)"	"unprognostic (2.68e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.82e-2)"	"unprognostic (8.59e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.80e-3)"	"unprognostic (8.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.80e-2)"	11.7	8.3	20.1	8.2	14.7	2.8	16.7	14.8	20.6	13.2	10.8	6.9	11.1	5.3	12.9	9.2	7.9	13.9	9.9	10.9	15.9	11.5	7.5	10.3	10.0	4.4	11.5	12.7	15.9	31.7	12.8	11.2	11.6	11.3	14.3	8.6	7.5	29.8	10.1	8.6	6.9	6.4	14.5	9.9	5.8	13.8	5.4	9.4	0.9	11.9	4.6	4.3	9.6	18.3	0.0	0.8	0.8	4.5	0.2	0.0	1.2	4.1	1.6	3.3	0.5	5.2	9.6	1.0	6.0	9.1	4.8	5.6	0.0	4.6	0.0	2.9	11.4	5.4	0.7	1.0	0.7	3.1	0.0	0.0	0.0	0.3	0.3	4.4	0.0	0.0	6.6	4.3	2.7	0.0	13.5	3.8	0.0	0.0	0.8	2.9	4.4	0.0	0.1	3.8	0.4	4.6	0.0	0.0	0.2	8.6	3.0	4.6	0.0	2.5	3.8	12.3	3.7	6.4	9.2	9.3	7.0	0.8	5.2	5.1	0.1	0.0	0.0	21.5	0.9	4.8	0.0	4.5	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.8	0.2	1.5	0.7	0.0	1.2	20.1	14.7	14.8	20.0	15.9	11.5	11.5	12.7	11.3	9.4	0.0	7.4	0.0	6.2	5.6	11.5	5.3	5.1	4.0	3.4	7.0	9.8	4.5	0.0	5.6	0.9	13.5	1.1	0.0	8.8	1.5	5.8	10.2	0.0	6.0	9.7	4.8	1.7	6.2	11.1	1.3	10.0	3.0	8.5	0.0	10.9	9.4	7.5	3.5	11.0	2.2	11.5	6.5	11.3	1.4	1.9	2.8	8.9	0.5	4.3	5.6
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 178.1;Late spermatids: 275.2;Pancreatic endocrine cells: 259.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.2;HEK 293: 56.9;HeLa: 53.2;SK-MEL-30: 53.1"					"Low region specificity"	"Detected in some"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli		NA	NA			Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: AB_2680174"	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavorable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favorable (5.19e-4)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.7	35.1	3.5	50.2	7.2	32.3	1.6	0.0	6.0	5.9	36.5	15.9	31.0	56.9	0.0	53.2	2.3	1.5	3.6	3.0	3.8	0.0	19.8	11.0	42.3	2.0	0.0	0.0	33.0	18.0	0.1	0.3	0.0	0.4	4.0	29.3	0.0	13.4	26.5	4.0	0.0	33.1	2.3	38.2	6.3	53.1	1.7	7.5	0.1	6.6	0.1	0.4	0.0	0.1	14.7	8.3	29.5	0.0	9.5	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9	0.0	0.0	1.5	0.7	1.5	0.2	4.0	0.0	14.7	1.2	10.4	0.0	20.9	0.0	32.4	178.1	2.2	6.9	0.0	22.9	52.3	3.6	10.0	4.6	0.0	6.6	0.0	68.2	0.6	8.2	275.2	2.8	1.8	8.5	26.2	6.2	0.8	259.8	10.5	1.8	0.0	0.0	0.0	1.0	5.7	4.1	0.4	7.7	12.5	2.3	34.0
DDX10	"Dbp4, HRH-J8"	ENSG00000178105	"DEAD-box helicase 10"	Q13206	11	108665025-108940930	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 58.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004691	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA004691: AB_1078629"	"unprognostic (9.49e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (2.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.43e-3)"	14.0	11.9	17.3	15.0	20.3	10.4	15.5	20.5	18.3	14.3	12.2	8.1	11.7	8.8	18.4	12.8	12.6	16.8	8.8	12.1	13.5	11.5	19.6	12.5	10.6	13.1	12.2	16.3	18.6	18.0	16.7	22.2	12.9	13.1	12.4	13.3	7.9	10.6	14.7	13.6	14.8	9.1	16.8	13.3	15.0	11.3	25.1	12.6	13.8	13.4	8.8	14.2	14.3	18.8	11.6	8.4	1.4	6.7	9.4	11.3	4.3	7.4	7.3	6.9	9.7	6.9	5.6	7.2	8.0	4.3	9.7	9.6	20.8	10.9	25.3	15.1	6.1	10.5	8.3	19.8	9.7	14.0	9.6	8.9	17.1	4.3	7.7	12.3	17.4	8.2	5.0	7.6	11.0	13.8	5.8	8.8	6.6	24.0	2.8	9.5	4.8	14.6	14.7	9.0	14.0	11.1	12.5	11.3	23.6	6.0	6.4	12.9	6.8	11.2	9.9	4.2	9.7	12.0	6.1	9.2	10.2	10.4	9.7	10.8	4.3	7.5	58.4	3.5	21.1	10.3	1.4	5.0	1.0	8.6	6.7	11.3	10.4	7.5	10.1	8.4	11.6	8.1	7.8	0.7	9.4	6.4	8.2	6.3	4.3	17.3	20.3	20.5	18.3	13.5	11.5	12.2	16.3	13.1	12.6	14.9	30.3	22.6	17.3	25.2	21.1	18.2	7.6	18.7	22.7	3.5	90.3	21.4	16.6	13.2	28.6	19.8	2.9	0.0	18.3	17.8	17.6	12.7	13.9	10.2	13.1	17.5	14.5	9.2	9.2	5.9	27.3	18.2	6.8	18.0	7.8	8.9	15.1	3.5	20.1	46.2	25.2	12.9	15.6	64.4	44.6	25.3	21.6	14.4	13.6	12.2
DDX27	"dJ686N3.1, DRS1"	ENSG00000124228	"DEAD-box helicase 27"	Q96GQ7	20	49219295-49244077	"Enzymes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047087	Uncertain		Approved	Nucleoli		Yes	No			Nucleoli		"HPA047087: AB_10964059"	"unprognostic (4.47e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (2.82e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (6.70e-7)"	"unprognostic (2.28e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.18e-2)"	"unprognostic (5.84e-3)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.26e-1)"	"unprognostic (4.32e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.27e-1)"	22.0	22.5	21.9	33.0	23.2	40.9	23.6	34.8	26.3	24.3	26.4	16.3	20.4	23.2	26.2	19.1	26.5	23.9	27.1	19.2	22.6	17.3	25.9	21.0	20.1	32.3	19.9	18.8	37.4	27.3	25.9	25.6	23.9	21.2	22.0	22.1	14.4	22.9	24.3	32.9	27.8	33.6	20.0	20.7	34.1	22.9	25.0	24.0	30.6	23.5	19.4	35.3	24.0	27.2	30.4	28.0	22.2	24.2	18.2	26.7	18.6	20.2	19.3	9.9	7.6	11.0	10.2	28.2	13.5	11.1	42.6	19.8	62.7	22.7	24.1	25.2	10.9	37.0	28.8	22.0	21.6	31.7	8.5	12.9	18.3	16.2	30.4	16.2	23.1	21.5	10.8	25.4	24.8	19.1	9.7	7.0	19.0	24.9	13.4	13.8	13.6	24.3	30.6	18.7	24.8	25.1	21.0	24.6	22.2	15.4	15.7	12.9	15.3	37.6	54.4	22.6	14.3	28.8	26.9	8.8	27.4	24.1	22.9	28.0	15.3	16.5	31.6	17.5	18.5	17.6	11.1	19.8	22.2	21.7	21.2	22.8	29.4	20.6	19.7	23.3	30.4	26.7	20.3	8.1	18.2	24.2	28.0	26.3	18.6	21.9	23.2	34.8	26.3	22.6	17.3	19.9	18.8	21.2	24.0	26.8	43.1	49.7	41.1	31.7	24.0	22.7	20.4	40.2	45.5	31.4	13.7	49.9	16.6	46.3	131.4	24.2	38.6	0.0	38.0	41.7	28.8	24.4	110.8	20.3	29.9	27.0	29.7	12.3	16.4	107.1	36.8	41.8	18.6	43.3	30.5	32.3	46.2	37.4	31.8	34.2	27.6	25.8	29.7	67.4	60.0	28.1	62.4	50.1	43.2	37.1
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 21.7;Exocrine glandular cells: 15.4;monocytes: 16.2;Pancreatic endocrine cells: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.7	17.2	16.9	13.7	16.7	16.4	28.9	17.1	19.7	36.6	34.3	26.0	25.7	20.5	6.7	23.2	22.7	26.0	24.2	19.7	41.3	28.9	17.4	18.7	12.8	14.8	14.2	21.3	12.1	15.8	18.8	21.7	18.0	28.8	28.1	16.2	18.1	4.6	20.0	14.2	17.2	14.8	74.3	18.5	10.6	19.2	32.9	12.4	22.3	28.7	7.4	18.8	20.8	13.4	17.0	43.8	5.4	16.1	12.6	14.8	35.9	9.5	25.7	6.5	11.8	37.1	15.7	11.2	17.0	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8	3.0	8.0	0.9	2.5	1.9	0.8	0.1	0.0	10.7	13.6	0.0	0.0	1.3	1.7	21.7	0.1	1.6	2.0	0.0	15.4	1.6	1.0	1.6	11.5	0.8	0.7	0.0	4.6	1.3	0.6	0.0	0.6	1.3	0.0	16.2	4.5	1.4	18.4	2.9	0.4	0.6	1.3	6.5	0.5	0.2	0.6	1.6	1.1	5.0	6.2	2.0
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.8	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	11.7	17.4	21.5	15.2	23.5	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	33.6	15.0	22.0	24.1	15.4	23.0	15.5	26.9	27.0	12.9	18.6	28.1	23.3	25.3	4.6	14.7	11.6	15.5	21.4	15.2	17.8	22.8	21.6	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3	17.9	17.1	30.4	30.5	10.5	42.7	23.6	20.4	29.4	34.2	19.2	37.3	35.2	48.0	24.1	57.6	24.3	8.9	0.0	21.8	33.0	25.7	18.5	40.6	13.5	20.5	35.0	15.5	22.1	18.1	12.1	33.6	21.7	11.8	39.7	18.2	20.9	20.8	18.4	36.7	25.1	51.1	19.4	28.1	54.0	56.0	12.5	34.4	41.5	21.3	16.8
DHX33	"DDX33, DKFZp762F2011, FLJ21972"	ENSG00000005100	"DEAH-box helicase 33"	Q9H6R0	17	5440912-5469060	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073875	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA073875: AB_2686638"	"unprognostic (4.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.03e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.37e-2)"	10.0	10.4	11.6	11.0	14.6	7.0	12.9	15.8	22.0	9.0	8.7	14.1	8.6	8.6	12.4	7.9	11.2	11.2	9.2	7.7	9.7	7.0	8.2	13.4	8.0	10.1	11.0	13.2	11.1	12.1	16.5	7.3	11.5	10.3	10.0	10.7	11.3	10.4	10.8	13.9	12.5	8.7	11.1	8.0	11.1	9.6	10.1	11.7	8.4	9.5	9.4	10.3	9.6	9.5	3.7	3.4	2.6	3.5	3.0	2.5	0.7	10.3	15.4	9.8	17.6	4.1	8.4	12.3	10.3	6.4	15.9	12.8	9.6	4.5	25.5	7.2	8.4	6.3	12.3	20.0	16.1	20.4	8.2	19.2	10.1	12.6	16.3	8.2	13.5	9.1	7.1	9.8	16.9	23.2	4.7	11.7	12.4	13.4	12.6	8.7	7.3	13.6	7.4	21.8	6.9	7.8	18.3	14.5	13.8	7.2	8.1	8.6	12.4	10.7	9.3	15.9	8.7	7.2	7.1	10.9	11.0	11.6	8.7	21.7	4.7	5.1	13.1	7.8	16.0	15.7	0.6	3.5	1.8	2.2	1.4	2.1	2.5	2.5	1.4	1.4	3.7	2.5	2.4	2.6	3.0	1.3	3.4	1.8	0.7	11.6	14.6	15.8	22.0	9.7	7.0	11.0	13.2	10.3	11.7	11.9	10.4	3.0	12.0	18.7	16.4	13.4	20.4	5.3	11.4	7.0	19.6	7.3	1.7	6.5	40.0	11.1	5.7	0.0	13.2	7.9	14.1	7.4	3.5	25.4	5.4	12.7	8.7	12.3	15.3	4.8	7.2	8.2	13.5	1.0	10.6	14.7	9.5	3.5	9.2	6.3	10.1	0.0	11.3	11.2	15.2	17.3	4.2	4.5	11.0	10.8
EFHB	"CFAP21, FLJ25200"	ENSG00000163576	"EF-hand domain family member B"	Q8N7U6	3	19879472-19947025	"Predicted intracellular proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.3;testis: 19.2"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 129.8;Early spermatids: 43.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	33	"RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA078067			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078067: AB_2732370"	"unprognostic (9.70e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.51e-5)"	"unprognostic (4.43e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	1.1	1.5	3.9	0.7	6.0	0.7	1.8	0.7	4.3	2.0	0.7	6.5	0.0	0.6	2.0	7.8	1.0	23.3	1.3	0.8	6.3	4.7	1.8	0.7	3.9	0.7	4.4	2.2	5.5	0.5	0.5	1.6	1.0	9.5	1.0	1.0	2.3	0.6	1.3	0.7	1.1	0.6	1.6	3.1	1.2	0.6	19.2	6.0	0.0	1.2	0.0	0.8	0.7	0.6	1.3	0.6	1.1	0.8	0.4	2.2	0.4	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	21.5	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	2.2	0.1	0.1	0.8	0.3	0.4	0.0	1.3	0.5	0.3	1.1	0.4	0.3	0.6	0.0	0.4	3.9	6.0	0.7	3.8	6.3	4.7	4.4	2.2	9.5	6.0	0.0	0.6	0.0	0.4	0.1	0.5	0.3	7.6	129.8	20.5	3.5	2.0	0.8	5.0	0.3	43.0	0.2	0.5	0.0	0.2	0.4	1.1	0.3	3.5	0.4	0.4	1.6	1.2	0.6	1.3	16.0	2.3	0.7	0.0	0.0	0.0	3.6	0.4	0.0	2.1	4.5	0.7	0.0	0.3	18.4	3.3	0.1	0.7	0.0	0.3	0.1
GLCCI1	"FAM117C, GIG18, TSSN1"	ENSG00000106415	"Glucocorticoid induced 1"	Q86VQ1	7	7968794-8094272	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 55.7"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 77.4;Bipolar cells: 61.8;Early spermatids: 62.5;Spermatocytes: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.7;U-266/70: 41.2;U-698: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001674, HPA005987"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA001674: AB_1078971, HPA005987: AB_1078970"	"unprognostic (6.12e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.02e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.57e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.17e-3)"	"unprognostic (3.35e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.20e-3)"	4.6	4.3	5.6	19.1	12.5	7.6	4.1	26.6	8.0	5.4	4.9	3.4	0.9	5.7	3.4	1.8	3.0	2.8	3.9	2.2	3.7	4.1	3.9	3.8	18.4	13.8	3.1	5.6	5.1	2.3	8.0	6.5	9.3	4.4	3.2	4.7	3.1	6.3	2.0	3.0	7.5	5.6	2.5	3.2	9.2	6.4	14.2	3.7	55.7	20.7	1.9	15.9	7.7	3.3	3.1	2.4	3.7	0.4	4.7	4.5	0.7	2.3	0.3	3.9	0.9	1.2	1.7	0.8	2.0	2.8	1.2	1.1	1.2	0.8	6.5	0.5	1.6	2.0	0.4	3.6	1.1	1.6	3.2	2.8	1.9	5.0	0.8	2.0	3.0	2.8	0.8	1.3	0.8	2.7	2.0	1.0	2.4	7.0	17.7	2.1	1.3	1.4	3.0	9.8	1.0	2.4	6.9	3.0	3.4	1.1	2.7	6.5	12.8	3.1	3.9	0.2	11.1	4.6	7.9	0.9	2.2	1.0	1.9	1.0	41.2	13.1	18.6	2.3	3.2	1.6	3.7	0.1	1.5	2.7	0.4	2.5	1.8	2.8	2.0	0.1	3.1	1.6	1.8	1.2	4.7	0.1	2.4	4.5	0.7	5.6	12.5	26.6	8.0	3.7	4.1	3.1	5.6	4.4	3.7	77.4	34.3	13.7	7.2	9.2	61.8	5.7	0.0	5.3	31.8	7.0	41.2	10.4	1.7	0.7	62.5	3.8	2.4	0.0	1.4	7.5	6.9	15.8	5.7	5.9	10.7	7.9	18.6	6.7	3.5	12.3	7.5	5.2	8.5	0.0	6.2	14.3	2.4	3.5	10.6	1.5	20.5	6.5	6.4	66.0	37.4	11.4	24.0	18.7	3.9	8.0
GTSF1L	"C20orf65, dJ1028D15.4, FAM112A"	ENSG00000124196	"Gametocyte specific factor 1 like"	Q9H1H1	20	43726164-43726998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 104.1"	"Group enriched"	"Detected in some"	119	"Early spermatids: 2558.4;Late spermatids: 2369.0"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 7.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.3;EFO-21: 1.3;REH: 4.0;U-698: 4.4"	"Low region specificity"	"Detected in some"							HPA054694	Enhanced		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA054694: AB_2682576"	"unprognostic (2.61e-2)"	"unprognostic (4.24e-6)"		"unprognostic (9.96e-3)"		"unprognostic (1.30e-4)"		"unprognostic (3.50e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.15e-2)"	"unprognostic (3.06e-2)"		"unprognostic (2.45e-7)"	"unprognostic (1.19e-1)"	"unprognostic (9.54e-2)"		"unprognostic (6.07e-3)"	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	104.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	0.9	4.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	1.0	0.0	1.4	0.6	0.8	0.0	0.0	0.0	0.0	7.5	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2558.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2369.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	6.5	0.0	20.6	8.0	0.0	0.0	0.0	0.0	0.0
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Cell type enhanced"	"Detected in many"	4	"Horizontal cells: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli		NA	NA			Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	11.5	13.5	9.6	15.0	13.8	11.7	16.7	11.1	20.6	16.8	21.2	18.9	14.1	11.0	13.1	15.2	35.9	8.5	18.1	19.1	14.6	10.2	13.0	9.6	14.2	9.2	19.2	18.4	21.9	15.2	14.4	24.5	19.4	21.4	11.9	8.9	12.6	11.6	17.6	9.1	11.4	9.6	7.2	7.7	20.3	10.0	13.3	10.6	10.0	14.4	12.4	12.4	9.7	23.9	24.7	8.7	11.1	12.0	10.2	25.1	10.7	12.1	20.5	13.6	12.9	15.7	29.3	14.1	12.9	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3	8.9	13.8	19.3	22.2	10.1	30.5	6.7	17.8	30.8	21.6	8.7	33.4	13.0	18.3	19.2	5.0	17.9	6.9	0.0	19.0	10.2	11.0	28.3	17.4	11.3	23.8	68.3	14.9	16.0	9.4	1.6	12.4	12.5	3.3	27.1	10.4	22.7	26.2	8.6	11.7	8.5	42.8	12.9	8.5	22.9	20.4	10.7	12.9	12.5	14.0	24.4
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP4, U3 small nucleolar ribonucleoprotein"	Q96G21	2	130342225-130347810	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA066222: AB_2685638, HPA066673: AB_2685701"	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	19.0	15.7	13.1	19.5	15.7	17.9	14.2	6.6	25.1	9.4	12.2	11.7	9.2	15.6	11.1	7.4	20.1	9.2	12.7	30.5	11.8	10.1	13.5	29.1	10.6	22.2	14.9	12.7	9.0	36.3	2.6	7.4	10.5	15.4	9.5	3.4	7.1	26.0	12.5	52.3	10.8	15.5	12.5	8.5	11.2	16.4	9.1	13.7	8.5	12.0	10.9	11.5	17.1	9.7	34.8	31.6	7.0	26.8	26.6	25.4	26.7	19.4	17.8	0.8	15.0	2.9	3.5	13.9	11.9	5.7	8.5	8.8	38.4	12.4	52.2	18.7	5.7	8.4	11.8	1.6	12.5	0.3	11.9	13.4	16.0	5.0	32.3	15.8	15.0	11.5	5.8	7.7	15.2	6.8	1.2	8.5	12.4	17.9	16.1	2.2	36.2	11.2	6.3	13.5	9.1	23.6	15.7	6.3	26.7	3.7	13.8	9.2	10.3	9.1	27.7	9.9	0.2	10.6	10.8	9.4	16.0	15.3	16.9	24.6	16.3	20.1	43.3	12.3	9.6	22.5	2.4	25.5	7.0	25.4	26.8	22.6	34.8	22.4	21.9	29.3	30.7	22.4	22.2	2.9	26.6	25.1	31.6	21.5	26.7	13.1	15.7	6.6	25.1	11.8	10.1	14.9	12.7	15.4	13.7	14.9	22.7	67.7	56.9	94.6	23.3	49.6	61.1	13.4	33.0	41.8	3.9	56.3	86.2	67.2	18.1	38.3	44.6	23.3	95.4	82.6	49.8	54.8	46.1	77.4	68.9	15.9	52.4	25.8	29.9	46.7	28.4	45.9	74.2	73.1	42.6	14.0	74.6	45.6	24.1	115.0	21.1	25.8	72.6	26.3	45.4	96.5	41.2	37.4	60.5	76.3
KCNJ14	"IRK4, Kir2.4"	ENSG00000182324	"Potassium voltage-gated channel subfamily J member 14"	Q9UNX9	19	48455509-48466980	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 22.9"	"Cell type enriched"	"Detected in many"	8	"Rod photoreceptor cells: 311.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071765			Approved	Nucleoli		NA	NA			Nucleoli		"HPA071765: AB_2686444"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.33e-5)"	"unprognostic (5.77e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.26e-2)"	"unprognostic (7.05e-4)"	"unprognostic (7.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.43e-3)"	"unprognostic (4.92e-2)"	"unprognostic (5.02e-6)"	"unprognostic (1.47e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.82e-3)"	"unprognostic (4.41e-2)"	1.0	0.4	1.1	0.9	6.1	4.9	1.8	2.3	2.2	0.9	0.9	0.9	0.9	0.6	0.9	1.8	1.5	1.1	1.0	0.9	1.4	1.3	0.9	0.9	0.9	1.2	1.2	0.9	1.3	1.4	1.0	1.0	1.4	1.4	1.5	0.7	22.9	0.9	0.9	3.3	4.9	0.9	0.9	0.9	0.9	0.6	2.8	0.9	0.9	1.6	0.9	0.9	0.9	1.1	1.5	0.8	3.5	0.8	0.6	1.0	0.2	1.6	3.8	0.8	2.5	1.7	1.7	2.6	0.6	0.3	0.8	1.3	3.9	2.2	1.8	0.8	0.6	2.0	5.5	1.2	0.6	2.1	1.3	2.0	1.1	2.2	1.0	1.0	1.6	3.2	1.6	2.8	2.0	2.3	1.1	0.5	1.7	1.8	2.0	0.5	2.4	0.6	12.4	1.4	2.0	2.2	2.6	1.5	0.4	0.6	4.6	1.4	1.7	1.8	2.6	1.4	1.5	1.8	1.3	1.1	2.7	3.6	2.7	3.0	2.1	3.1	1.3	0.7	4.0	2.8	3.5	0.8	0.6	0.6	0.6	0.5	1.2	0.7	1.0	0.4	1.5	0.8	1.0	2.9	0.6	0.3	0.8	0.6	0.2	1.1	6.1	2.3	2.0	1.4	1.3	1.2	0.9	1.4	0.9	0.0	4.3	0.0	3.7	3.9	15.0	0.4	2.5	1.4	0.0	1.8	39.3	1.3	0.0	0.8	4.1	1.0	0.4	0.0	0.9	2.1	0.8	2.5	0.0	0.5	0.5	14.3	0.0	0.6	0.0	0.0	1.1	0.2	0.0	0.0	1.2	17.5	2.1	0.0	0.4	0.0	311.1	0.0	0.9	3.4	2.7	4.6	0.8	0.0	1.7	2.1
KLHDC4	DKFZp434G0522	ENSG00000104731	"Kelch domain containing 4"	Q8TBB5	16	87696485-87765992	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 59.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041665	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA041665: AB_10796352"	"unprognostic (2.96e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.61e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (3.84e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.88e-1)"	"prognostic favorable (1.69e-4)"	12.7	12.1	13.5	23.1	15.5	17.0	12.7	15.5	15.8	9.9	13.8	14.6	16.1	13.1	17.5	14.4	12.8	13.1	17.7	10.2	14.7	12.9	11.4	16.1	12.5	21.0	14.7	13.6	12.1	20.6	15.6	14.2	8.7	12.9	11.0	15.8	10.7	16.6	16.3	30.7	15.9	12.0	12.7	15.5	14.9	14.5	26.6	12.9	22.7	14.0	14.5	19.5	12.7	11.8	6.1	6.1	4.4	11.1	17.6	14.4	6.4	6.7	12.4	6.3	9.5	2.5	3.4	9.8	6.4	6.0	10.6	5.0	18.3	9.7	10.7	8.6	5.0	3.7	11.1	9.6	8.5	7.6	1.6	10.7	6.1	7.8	12.0	6.5	5.6	6.4	1.5	4.5	9.5	10.7	5.2	8.8	18.1	19.5	5.6	7.0	29.0	13.1	16.6	10.6	7.6	9.3	12.7	7.3	6.1	6.3	7.9	9.7	9.3	13.4	6.9	3.1	5.4	10.9	9.0	5.5	5.9	10.1	3.0	12.1	27.3	9.3	46.5	5.7	14.5	4.0	0.0	6.0	4.4	14.4	7.8	12.6	6.1	6.0	11.6	4.4	5.5	6.1	9.2	0.4	17.6	11.1	6.1	5.0	6.4	13.5	15.5	15.5	15.8	14.7	12.9	14.7	13.6	12.9	12.9	0.0	15.6	9.0	8.9	4.0	14.4	8.5	12.7	9.4	15.9	8.7	25.5	12.5	10.0	9.5	50.2	6.7	11.1	23.3	14.4	7.3	5.9	11.1	3.5	11.3	11.7	11.1	23.1	9.8	16.5	59.9	6.1	6.8	8.5	9.0	12.0	6.2	11.7	11.5	7.1	19.2	17.7	0.0	6.2	19.4	11.7	5.8	10.0	30.2	18.5	15.3
KREMEN2	"KRM2, MGC10791"	ENSG00000131650	"Kringle containing transmembrane protein 2"	Q8NCW0	16	2963944-2968383	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.1;skin 1: 12.5"	"Cell type enhanced"	"Detected in some"	9	"Basal keratinocytes: 12.6;Cone photoreceptor cells: 5.9;Mucus-secreting cells: 9.5;Rod photoreceptor cells: 10.0;Spermatogonia: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory B-cell: 3.2;naive B-cell: 3.0;non-classical monocyte: 1.4"	"Group enriched"	"Detected in many"	6	"B-cells: 3.2;monocytes: 1.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.3;MCF7: 10.2;RPMI-8226: 19.1;T-47d: 10.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA003223	Uncertain		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli		"HPA003223: AB_1079217"	"unprognostic (8.36e-2)"	"unprognostic (4.65e-1)"	"unprognostic (6.24e-3)"	"unprognostic (4.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.03e-2)"	"unprognostic (8.57e-2)"	"unprognostic (7.79e-12)"	"unprognostic (6.69e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.58e-3)"	0.2	0.1	1.6	2.0	0.7	1.7	0.2	0.2	3.0	1.8	0.4	0.2	4.5	0.3	0.3	0.8	3.8	0.6	0.3	0.2	1.9	0.3	0.2	0.2	0.2	0.8	0.7	0.2	0.2	0.4	0.0	0.2	0.2	0.3	1.6	0.0	1.9	1.6	0.2	0.6	12.5	0.6	0.2	1.7	0.9	0.5	2.1	0.2	13.1	0.2	1.8	6.8	0.2	0.6	3.2	0.3	0.0	1.4	0.0	0.0	0.0	1.2	0.8	0.3	7.3	0.0	0.0	1.1	0.4	0.0	0.0	0.0	2.9	1.1	5.3	1.5	0.0	0.8	6.0	0.9	0.5	0.0	0.8	0.8	0.3	1.7	1.7	0.0	0.4	20.3	0.2	0.0	0.0	0.1	0.6	0.0	0.6	2.1	2.1	0.0	10.2	1.2	2.4	2.0	2.1	1.5	3.2	8.3	19.1	0.0	0.2	2.1	1.2	1.4	3.3	3.3	0.2	10.3	1.9	0.1	0.6	8.9	0.7	0.5	3.8	0.8	3.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.6	0.7	0.2	2.3	1.9	0.3	0.7	0.2	0.3	0.2	0.0	0.0	0.0	0.6	12.6	0.4	0.8	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.4	0.0	0.5	0.0	2.4	1.6	0.0	2.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	3.3	0.0	9.5	0.2	0.2	0.2	0.0	0.0	10.0	0.0	0.0	0.5	5.9	4.8	0.1	0.0	0.2	0.3
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553078-10566037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	14.7	12.5	10.4	23.6	20.6	19.1	14.3	27.8	19.6	14.5	13.4	16.6	12.4	12.7	15.9	17.6	17.2	14.3	15.0	12.1	13.1	10.3	11.9	13.3	12.4	25.2	16.7	9.8	17.2	19.5	21.0	18.3	10.9	14.9	15.6	9.8	20.3	14.7	18.2	23.0	25.3	16.8	15.0	17.2	23.0	12.7	14.6	18.6	46.8	15.6	10.9	21.3	15.8	15.9	8.5	14.1	2.5	4.9	8.5	11.2	3.9	12.3	6.3	8.1	11.7	4.4	4.9	5.6	11.4	5.4	7.2	6.7	9.1	4.5	18.2	13.5	4.6	6.3	9.7	9.9	8.9	8.2	19.8	22.5	57.8	12.2	5.9	8.1	22.6	21.0	6.0	7.3	10.4	10.7	6.3	4.6	11.1	16.1	18.6	6.2	11.0	23.2	33.7	13.0	10.0	15.1	9.8	10.6	9.0	6.1	11.0	13.4	6.3	13.4	7.9	8.4	7.5	9.9	16.6	5.5	9.4	7.9	25.2	23.8	13.2	15.3	13.1	7.9	18.4	14.0	1.3	4.5	2.5	11.2	4.9	10.3	7.1	7.5	9.0	5.8	8.5	8.4	9.0	0.8	8.5	2.5	14.1	5.4	3.9	10.4	20.6	27.8	19.6	13.1	10.3	16.7	9.8	14.9	18.6	14.9	23.8	9.3	12.1	11.9	14.0	6.1	7.6	22.7	22.7	14.0	37.3	9.8	1.7	6.5	3.2	7.3	6.7	0.0	6.4	7.3	8.2	6.6	18.5	7.4	6.8	11.1	9.2	9.8	10.2	5.0	7.8	8.2	8.5	1.8	7.8	8.9	5.0	7.0	8.5	3.9	51.4	0.0	7.3	28.7	15.0	12.0	3.8	15.3	9.5	5.9
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.1;HSkMC: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	1.0	30.0	1.3	66.1	30.0	13.1	15.3	22.1	7.8	5.9	0.1	2.9	4.2	0.3	21.3	10.2	4.3	3.7	8.9	6.5	4.1	4.4	11.5	0.9	0.0	6.9	0.2	0.3	48.3	1.2	7.0	11.7	7.0	7.2	0.2	0.0	0.0	15.0	2.4	0.0	3.5	2.2	0.0	4.0	1.8	13.0	0.0	5.2	3.7	0.1	0.9	1.4	1.8	4.1	17.9	1.7	0.0	13.5	19.9	2.9	6.1	8.3	0.2	0.0	12.0	8.3	0.0	14.3	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9	3.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	18.2	0.0	0.0	3.1	1.7	0.6	0.0	0.0	0.0	0.0	0.6	146.6	0.0	0.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0
LRRC40	FLJ20331	ENSG00000066557	"Leucine rich repeat containing 40"	Q9H9A6	1	70144805-70205620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026564	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA026564: AB_2250054"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.54e-4)"	"unprognostic (6.42e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.94e-2)"	"unprognostic (7.69e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.50e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	14.3	10.4	15.7	10.0	18.5	16.4	13.2	22.0	27.4	13.4	10.7	10.4	8.0	17.0	12.6	10.2	11.5	9.0	10.1	13.5	16.5	16.6	20.4	27.2	9.6	14.2	13.7	15.7	11.3	8.8	7.9	13.8	13.9	19.8	10.6	11.8	7.5	9.0	8.8	13.6	9.0	18.0	13.3	15.6	13.2	9.0	13.4	11.0	23.0	9.9	10.0	14.2	11.1	9.6	10.4	8.4	7.4	8.2	9.8	10.9	6.5	11.3	4.7	18.9	14.8	6.9	7.7	11.4	11.0	8.0	16.7	20.6	6.9	6.4	15.3	9.7	8.5	16.5	8.4	44.3	9.8	22.8	12.2	8.9	11.5	8.7	11.1	8.7	15.0	2.8	6.4	5.7	11.1	11.2	7.7	9.6	9.8	14.2	7.4	14.0	2.9	18.1	11.8	24.8	7.5	10.0	14.5	19.5	9.9	15.2	7.0	9.7	9.8	13.2	13.3	12.2	14.0	6.3	8.6	11.9	11.8	9.5	17.8	12.4	6.3	6.0	24.8	9.5	15.9	12.1	6.8	6.6	7.4	8.5	8.2	10.9	10.4	9.0	7.9	8.4	9.2	10.6	8.8	0.9	9.8	7.6	6.5	10.8	6.5	15.7	18.5	22.0	27.4	16.5	16.6	13.7	15.7	19.8	11.0	11.9	9.3	7.5	7.2	11.4	14.9	9.2	5.1	6.7	6.8	14.0	5.9	14.2	10.0	11.9	0.9	8.9	6.7	23.3	7.6	11.1	13.9	5.2	15.0	17.4	10.1	14.3	22.3	12.3	11.7	1.9	9.5	8.0	5.0	10.8	5.8	6.6	7.9	3.5	9.6	20.3	11.9	19.4	12.3	19.1	25.5	9.7	6.1	12.9	7.7	5.0
MCEE	GLOD2	ENSG00000124370	"Methylmalonyl-CoA epimerase"	Q96PE7	2	71109684-71130239	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 76.7;Distal tubular cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035196			Approved	Nucleoli	"Intracellular and membrane"	No	No		16000	Nucleoli		"HPA035196: AB_10601871"	"unprognostic (7.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (4.76e-4)"	"prognostic favorable (5.78e-4)"	"unprognostic (4.86e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-3)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.51e-2)"	"unprognostic (5.38e-2)"	10.5	20.4	8.5	10.1	9.2	4.3	18.9	10.5	9.8	14.1	13.8	9.4	24.6	11.1	8.8	19.7	16.9	8.6	12.6	19.8	6.6	6.2	18.8	39.7	9.1	9.5	13.1	6.6	12.4	29.0	9.8	24.5	9.9	9.1	13.7	13.5	11.1	28.9	20.5	18.2	15.2	14.9	10.9	11.5	10.1	13.1	5.7	11.4	9.3	11.0	18.7	10.9	13.0	13.3	15.9	17.6	20.0	18.4	11.2	24.9	11.1	6.4	3.1	5.7	4.1	19.4	26.4	16.5	9.9	12.6	5.0	7.6	7.7	8.0	9.9	3.0	9.7	3.8	6.7	6.9	5.1	5.3	9.2	6.0	6.8	8.7	22.1	10.9	7.6	5.6	17.5	7.5	3.4	6.7	11.2	5.7	7.9	8.9	17.4	4.8	8.2	5.6	8.9	5.2	17.7	7.7	6.7	6.5	18.4	7.7	5.2	6.5	4.7	3.7	21.9	9.7	6.9	17.3	7.3	7.4	5.9	4.6	6.0	3.9	16.7	6.8	10.5	9.6	12.4	5.3	13.0	18.3	20.0	12.8	18.4	17.3	15.9	15.7	12.3	14.9	13.2	14.6	12.3	4.5	11.2	17.6	17.6	24.9	11.1	8.5	9.2	10.5	9.8	6.6	6.2	13.1	6.6	9.1	11.4	23.8	8.3	13.7	11.3	7.6	2.6	76.7	22.9	17.4	9.1	5.2	2.0	30.6	77.9	10.4	0.8	9.0	14.7	0.0	16.1	27.7	21.1	8.8	0.0	60.2	13.5	4.8	8.6	9.8	11.6	0.9	27.0	11.2	13.5	3.6	28.7	6.7	10.6	10.5	16.6	64.3	8.7	25.8	10.8	2.4	4.1	18.2	9.5	12.9	25.1	9.2
MED12L	"KIAA1635, TNRC11L, TRALP, TRALPUSH"	ENSG00000144893	"Mediator complex subunit 12 like"	Q86YW9	3	151085697-151437072	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 14.2;Horizontal cells: 31.8;Muller glia cells: 35.7;Syncytiotrophoblasts: 22.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.8;HEL: 17.1;JURKAT: 10.9;MOLT-4: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036807	Enhanced		Approved	Nucleoli		NA	NA			Nucleoli		"HPA036807: AB_10670242"	"unprognostic (1.01e-2)"	"unprognostic (5.82e-2)"	"unprognostic (5.12e-2)"	"unprognostic (8.14e-4)"	"unprognostic (2.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.23e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.84e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.92e-2)"	2.8	5.2	6.4	1.2	11.1	5.5	0.5	4.9	23.1	1.6	0.6	4.4	0.0	2.2	0.9	3.0	0.9	0.6	1.8	1.7	5.5	5.1	0.4	0.4	0.7	4.4	5.8	2.6	1.0	1.7	0.5	5.4	2.0	3.9	1.2	0.3	1.9	1.7	0.7	0.5	0.4	1.6	0.6	6.1	2.1	0.8	6.1	5.7	0.6	1.0	0.0	1.5	1.3	0.8	1.0	5.1	3.1	2.8	0.1	0.4	0.8	0.7	0.3	2.5	0.2	0.1	0.0	15.8	0.0	0.2	0.6	0.7	0.8	0.3	0.0	0.2	0.1	1.8	0.1	3.2	0.2	0.7	0.0	1.5	17.1	0.1	0.1	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.0	10.9	0.0	2.6	0.0	2.5	7.9	0.0	2.9	0.1	0.5	0.1	0.9	0.4	0.2	2.5	4.2	0.6	0.4	0.2	0.0	4.6	0.8	0.1	0.0	0.0	1.9	0.0	1.3	5.0	0.0	6.1	0.2	1.5	0.9	3.1	0.3	0.0	0.1	2.8	0.4	0.1	0.1	0.2	1.6	1.0	0.0	0.0	0.3	0.1	0.8	5.1	0.0	0.8	6.4	11.1	4.9	6.9	5.5	5.1	5.8	2.6	3.9	5.7	0.0	0.0	0.0	1.2	1.0	9.0	1.2	0.0	1.4	2.3	1.8	3.9	14.2	0.0	0.1	9.9	0.1	0.0	0.0	0.5	0.6	0.6	1.0	0.0	0.0	1.6	31.8	0.0	0.6	1.0	4.5	0.9	0.9	0.0	1.8	0.0	35.7	0.2	0.0	0.4	0.1	1.8	0.0	0.1	7.5	1.5	0.1	22.5	0.0	0.0	0.1
MED16	"DRIP92, THRAP5, TRAP95"	ENSG00000175221	"Mediator complex subunit 16"	Q9Y2X0	19	867630-893218	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030685, HPA046495"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA030685: AB_10601872, HPA046495: AB_2679674"	"unprognostic (1.63e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"prognostic favorable (5.46e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-2)"	"unprognostic (4.93e-3)"	"unprognostic (3.28e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (4.83e-2)"	"unprognostic (5.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.17e-2)"	17.8	19.8	17.0	24.2	21.1	16.1	15.9	16.8	34.5	21.8	20.4	21.4	12.5	20.5	20.7	14.9	21.0	20.3	21.9	14.0	16.0	15.4	19.4	29.5	16.2	19.4	13.4	16.3	28.6	46.1	18.9	18.8	21.9	14.7	20.6	8.5	19.4	24.4	15.6	31.1	24.6	24.4	14.9	11.2	22.3	27.0	20.1	14.0	27.0	21.6	16.1	21.6	20.5	18.9	30.3	20.8	24.7	17.0	19.2	40.3	25.4	14.1	12.3	12.4	8.3	5.3	5.6	13.6	9.6	9.5	14.8	11.4	16.0	13.6	14.7	11.9	8.9	5.1	11.2	4.7	11.9	2.5	18.2	14.9	14.7	9.2	14.7	10.3	13.8	13.3	9.7	6.0	9.1	6.0	8.9	10.9	15.7	17.1	34.0	8.6	21.3	22.2	16.3	19.2	5.5	16.0	23.3	8.9	18.7	9.9	22.8	15.4	15.0	13.4	9.2	10.8	4.9	10.5	11.1	10.9	15.3	15.4	23.1	11.1	25.7	9.2	13.4	19.6	13.1	11.0	24.7	15.7	19.0	27.6	17.0	25.0	30.3	30.3	31.5	20.8	23.1	25.8	23.8	22.2	19.2	16.9	13.6	40.3	25.4	17.0	21.1	16.8	34.5	16.0	15.4	13.4	16.3	14.7	14.0	32.8	21.9	14.5	10.0	10.3	14.2	6.4	15.3	12.0	12.5	21.0	5.9	50.4	14.9	19.5	2.9	10.9	35.5	0.0	20.9	26.3	11.3	12.1	13.9	22.5	22.0	14.3	24.6	18.4	16.8	4.7	12.7	9.4	10.1	29.7	24.7	16.5	20.5	27.5	13.8	14.6	19.2	6.5	11.3	13.7	30.5	14.1	53.3	16.6	22.2	12.9
MXRA8	DKFZp586E2023	ENSG00000162576	"Matrix remodeling associated 8"	Q9BRK3	1	1352689-1361777	"Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Extravillous trophoblasts: 236.0;Fibroblasts: 92.6;Leydig cells: 163.1;Peritubular cells: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"naive CD8 T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.7;BJ: 50.0;BJ hTERT+: 23.5;fHDF/TERT166: 24.8;HHSteC: 15.7;HSkMC: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053958, HPA055780"	Uncertain		Approved	Nucleoli		NA	NA		450000	Nucleoli		"HPA053958: AB_2682322, HPA055780: AB_2682918"	"unprognostic (1.39e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.43e-6)"	"prognostic unfavorable (9.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (9.87e-4)"	45.6	5.3	2.3	11.4	4.6	1.1	25.2	3.9	3.8	34.8	14.3	4.8	6.2	6.5	34.0	16.3	13.7	14.4	20.5	12.7	3.6	1.1	7.6	3.5	13.4	5.6	2.6	2.6	30.4	3.7	1.6	6.0	25.0	5.4	23.4	2.3	36.6	8.4	12.3	15.5	10.9	8.6	22.0	4.5	9.5	8.7	16.4	2.9	0.3	13.9	11.8	4.5	22.3	17.8	0.0	0.0	0.0	0.0	0.0	9.8	0.3	1.3	0.3	0.4	0.3	6.0	16.7	15.1	50.0	23.5	5.9	7.0	2.7	1.1	0.5	0.2	24.8	0.0	1.0	0.3	0.0	1.1	1.0	0.4	0.4	0.9	4.2	15.7	0.0	0.5	19.9	0.0	2.2	0.0	11.1	0.0	0.3	5.8	0.5	7.4	0.1	0.1	0.1	4.9	0.1	1.6	0.2	0.1	0.1	0.0	0.2	1.1	3.1	0.1	0.5	0.0	3.6	3.9	0.2	0.4	0.2	8.3	7.7	0.2	1.1	0.1	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	9.8	0.0	0.0	0.0	0.0	0.0	0.3	2.3	4.6	3.9	2.7	3.6	1.1	2.6	2.6	5.4	2.9	3.0	0.0	0.0	0.8	9.5	0.7	3.2	0.0	0.0	0.0	8.7	0.0	5.9	0.0	4.6	1.4	1.6	0.0	0.0	0.0	236.0	92.6	0.5	0.0	0.0	8.3	0.0	0.0	9.8	0.0	6.1	163.1	1.6	10.1	1.0	0.0	44.6	0.8	0.0	172.5	1.5	1.0	12.9	36.9	0.7	5.2	9.3	24.6	0.0	0.0	0.3
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell type enhanced"	"Detected in some"	21	"Collecting duct cells: 5.2;Early spermatids: 12.4;Late spermatids: 22.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.0;SK-BR-3: 3.5;T-47d: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA			Nucleoli		"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	7.0	0.1	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.5	0.0	1.2	15.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.7	0.8	0.0	0.0	0.0	5.2	0.0	0.2	3.3	0.8	12.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	22.2	0.9	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.4	0.5	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.0
NOL10	"FLJ14075, PQBP5"	ENSG00000115761	"Nucleolar protein 10"	Q9BSC4	2	10570766-10689987	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 120.4;Late spermatids: 122.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035286, HPA043075"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA035286: AB_2674552, HPA043075: AB_10794652"	"unprognostic (6.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.84e-2)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.43e-7)"	"unprognostic (1.25e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (7.51e-5)"	"unprognostic (2.43e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.87e-2)"	18.6	22.4	13.5	18.7	16.1	20.5	17.7	20.4	16.9	14.7	15.5	16.2	19.6	13.1	21.5	19.1	20.9	11.8	15.7	15.7	11.6	11.8	18.2	21.9	13.8	17.5	17.4	12.5	15.2	25.8	17.0	21.4	19.8	16.2	15.2	17.6	14.4	19.8	15.5	27.5	19.4	13.5	15.2	17.0	15.3	17.2	18.4	15.4	16.4	16.8	21.3	18.9	14.6	18.2	8.1	7.4	3.6	8.5	7.0	9.7	4.4	11.3	18.4	10.8	19.3	12.9	14.2	21.4	19.3	15.1	20.5	16.1	21.7	14.6	26.6	12.0	17.1	17.0	14.8	25.5	23.3	25.9	18.6	20.0	25.7	11.6	25.6	17.2	29.6	14.3	12.7	17.2	22.9	22.8	9.8	14.7	14.0	33.8	16.9	20.2	20.5	19.6	21.3	30.0	30.1	17.4	18.3	29.7	24.7	14.5	15.6	18.8	20.4	14.5	23.9	16.8	12.3	12.5	11.6	14.5	20.1	24.8	20.6	31.5	22.7	35.5	30.7	16.9	29.3	24.7	2.5	6.1	3.6	6.8	8.5	9.6	8.1	7.1	7.7	7.4	6.3	5.5	7.6	0.8	7.0	8.3	5.3	9.7	4.4	13.5	16.1	20.4	16.9	11.6	11.8	17.4	12.5	16.2	15.4	14.9	18.4	13.7	24.7	29.3	13.5	16.9	12.7	8.1	14.8	12.2	11.8	28.1	13.3	17.7	120.4	20.4	8.9	0.0	20.8	26.8	16.9	16.3	13.9	9.6	13.7	15.9	10.9	12.3	10.0	122.0	15.8	13.9	8.5	21.6	11.6	12.0	15.2	3.5	15.6	13.9	15.2	12.9	23.9	25.6	42.0	29.9	24.7	15.2	15.8	19.5
NOL11	DKFZP586L0724	ENSG00000130935	"Nucleolar protein 11"	Q9H8H0	17	67717833-67744531	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022010	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA022010: AB_2267158"	"unprognostic (6.81e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.00e-6)"	"unprognostic (3.07e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavorable (2.59e-6)"	"unprognostic (1.37e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.77e-3)"	"unprognostic (8.74e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.11e-1)"	17.3	15.1	12.2	14.3	13.4	17.0	14.5	19.8	11.6	15.2	12.9	10.2	11.9	10.3	17.2	11.7	18.1	13.9	10.4	12.8	9.5	7.6	18.9	22.1	10.4	17.5	14.4	5.4	19.5	16.9	18.4	17.0	19.8	10.8	14.6	13.9	10.4	14.1	10.7	26.8	13.8	13.8	13.6	11.1	16.6	14.4	10.6	14.3	32.1	13.6	16.4	20.1	14.5	13.4	9.7	7.0	7.4	5.8	10.0	14.7	7.8	14.7	17.3	14.5	9.4	6.9	8.2	15.8	10.3	8.9	22.9	18.8	16.3	11.4	25.1	8.0	11.1	14.1	11.5	35.3	17.0	33.7	7.1	28.0	16.5	10.5	14.5	8.0	22.0	10.8	6.4	10.8	17.2	11.8	6.4	21.3	12.1	27.5	7.8	18.2	14.5	27.0	9.2	15.9	18.4	24.1	18.6	30.4	17.6	10.3	17.5	12.0	11.1	9.5	26.9	12.4	21.2	18.3	12.4	7.3	20.0	13.5	6.8	21.3	4.9	12.5	27.1	8.6	15.4	11.9	7.4	5.2	3.6	8.5	5.8	8.8	8.8	8.9	10.2	7.0	9.7	14.7	10.8	0.8	10.0	5.3	5.3	9.6	7.8	12.2	13.4	19.8	11.6	9.5	7.6	14.4	5.4	10.8	14.3	26.8	15.2	15.2	29.1	29.8	21.5	15.7	25.5	28.1	23.9	8.7	13.7	39.2	10.0	17.7	0.9	22.8	10.5	0.0	15.3	29.4	23.4	12.5	23.1	21.2	17.9	23.8	26.4	14.7	13.7	3.4	19.2	15.4	16.9	15.4	15.5	15.8	14.4	7.0	18.0	23.8	31.9	6.5	16.5	20.6	34.1	29.1	27.6	24.9	18.9	23.5
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.1	7.9	5.8	8.7	5.9	6.2	8.0	9.2	4.5	7.5	6.1	8.5	7.8	16.1	9.3	7.4	7.6	7.5	10.5	11.1	9.2	7.3	9.2	13.5	6.6	7.9	4.8	23.5	8.3	4.4	5.5	6.7	8.7	4.3	6.3	9.1	20.3	8.7	6.7	12.0	14.8	19.7	14.1	8.2	8.6	10.6	8.9	12.4	4.8	11.0	7.2	8.8	8.4	6.7	6.3	6.9	3.2	12.7	10.1	8.1	2.6	15.0	11.8	11.2	8.0	14.9	10.4	17.0	7.6	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9	8.9	16.5	13.4	26.4	34.9	15.8	9.2	12.7	17.4	18.2	5.2	19.6	12.5	3.3	16.5	7.2	14.4	6.4	0.0	11.8	17.3	12.0	18.5	19.8	13.1	12.8	11.1	7.5	6.7	10.5	1.8	16.1	18.2	23.6	14.4	10.4	9.8	12.4	10.5	12.4	4.9	30.5	0.0	14.6	28.2	35.7	37.1	6.1	12.8	14.6	26.9
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 179.6;Suprabasal keratinocytes: 179.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	17.1	12.8	11.0	15.3	12.7	13.2	13.5	6.1	10.4	8.5	13.3	4.9	8.4	12.0	9.5	8.1	23.2	9.6	9.9	18.2	8.0	8.2	18.2	34.3	8.7	15.0	11.0	8.8	10.9	16.2	5.8	7.2	9.5	14.8	9.1	11.8	3.2	8.8	7.7	50.2	15.6	9.5	8.7	6.8	14.7	11.2	12.2	9.5	9.4	11.3	29.3	17.1	11.1	12.2	26.8	30.3	2.7	26.6	24.1	22.6	13.7	17.6	27.0	6.7	28.6	9.9	10.4	26.1	14.7	8.7	21.3	18.5	37.0	17.8	29.5	20.1	10.9	21.6	16.7	31.5	48.6	14.9	37.5	25.7	15.2	19.9	31.3	20.0	31.1	18.0	10.8	21.9	19.5	24.2	7.0	15.5	14.5	29.7	15.1	15.3	51.4	23.7	42.9	23.7	27.0	34.3	19.9	9.5	31.3	19.8	15.1	20.2	17.0	8.6	35.0	19.5	6.8	15.6	22.8	14.0	16.3	16.7	15.2	36.6	19.4	23.0	32.7	12.7	42.6	14.0	2.1	16.8	2.7	17.4	26.6	22.6	25.1	19.6	18.7	24.9	26.8	21.5	22.5	1.7	24.1	13.0	30.3	13.6	13.7	11.0	12.7	6.1	10.4	8.0	8.2	11.0	8.8	14.8	9.5	6.0	18.7	26.1	87.2	179.6	3.6	28.3	30.6	17.4	51.2	1.8	3.9	42.2	31.5	52.0	5.5	36.6	15.8	0.0	45.6	43.9	34.5	39.0	25.5	35.6	34.5	0.0	20.1	9.2	8.5	3.1	18.1	22.4	54.0	27.1	25.0	3.4	46.9	8.6	13.8	56.7	2.9	6.5	76.9	28.6	31.6	179.5	32.0	17.3	40.3	81.4
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Enhanced	Nucleoli		No	No			Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.3	26.4	7.2	24.7	9.2	7.9	39.2	14.9	9.6	17.7	15.3	32.2	16.7	35.1	4.1	7.3	18.6	20.3	27.6	16.5	17.2	41.4	25.9	34.4	25.2	18.6	12.4	33.8	19.8	8.0	16.3	21.4	33.3	7.8	11.9	18.8	24.1	5.6	14.0	20.3	18.1	29.4	60.3	21.9	14.8	25.9	21.1	17.2	12.9	22.7	5.5	11.0	23.4	25.5	12.3	29.8	4.2	16.2	11.2	12.2	16.3	15.8	34.3	7.8	11.4	52.4	11.2	19.4	21.1	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2	11.9	5.0	12.3	13.4	21.2	5.5	5.6	5.1	2.7	1.2	3.5	2.0	10.0	1.7	10.0	16.0	8.0	2.9	0.0	10.3	10.4	8.5	9.5	7.0	6.6	10.6	6.4	6.9	9.8	9.2	6.6	8.6	8.1	8.5	9.0	7.6	2.5	10.6	5.8	4.6	1.0	2.8	12.9	12.0	10.7	19.5	18.6	6.1	7.2	11.2	11.5
NOP53	"GLTSCR2, PICT-1, PICT1"	ENSG00000105373	"NOP53 ribosome biogenesis factor"	Q9NZM5	19	47745522-47757058	"Predicted intracellular proteins"	"Host-virus interaction, Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 374.2;Exocrine glandular cells: 855.6;Extravillous trophoblasts: 474.7;monocytes: 470.7;Pancreatic endocrine cells: 426.7;Syncytiotrophoblasts: 423.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 51.0;NK-cells: 20.5;T-cells: 52.7"	"Cell line enhanced"	"Detected in all"		"NB-4: 161.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018999, HPA049600"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA018999: AB_1849733, HPA049600: AB_2680831"	"unprognostic (2.08e-3)"	"unprognostic (1.84e-1)"	"unprognostic (4.02e-3)"	"prognostic favorable (2.35e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	35.2	34.8	13.4	35.1	19.7	39.3	40.6	21.0	21.6	44.4	36.9	15.4	30.7	35.9	41.4	30.8	37.2	32.2	36.1	24.5	12.7	10.2	24.8	24.7	22.6	48.7	18.2	19.7	90.1	92.0	18.6	19.8	20.3	16.1	42.3	12.7	22.8	67.3	28.2	51.6	54.7	32.8	50.2	16.4	49.8	39.0	31.9	17.4	49.7	54.9	33.8	40.9	39.6	68.7	51.0	8.8	4.8	7.2	20.5	52.7	2.9	12.3	13.0	11.7	27.6	14.6	24.5	22.2	7.7	14.2	7.5	11.1	12.0	24.9	54.1	11.1	8.9	5.7	17.6	6.7	11.3	3.9	15.8	22.4	17.7	11.0	14.0	21.6	25.5	34.8	21.5	26.0	6.6	17.8	24.6	11.8	23.4	21.5	26.7	6.7	10.7	69.3	161.6	26.7	21.6	7.5	46.5	20.9	25.1	14.3	19.1	12.4	43.5	6.5	42.7	38.5	9.0	20.1	62.1	14.5	7.4	19.7	6.3	15.7	39.0	34.8	14.7	9.3	18.2	11.8	3.6	4.8	4.8	12.0	7.2	16.7	51.0	23.9	21.2	6.9	36.0	52.7	24.0	0.7	20.5	5.0	8.8	22.7	2.9	13.4	19.7	21.0	21.6	12.7	10.2	18.2	19.7	16.1	17.4	38.7	121.7	0.0	0.0	0.0	0.0	0.0	0.0	33.5	127.4	99.5	0.0	374.2	225.5	211.0	0.0	0.0	0.0	0.0	855.6	474.7	0.0	0.0	62.8	0.0	225.5	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	470.7	0.0	0.0	426.7	0.0	0.0	291.0	0.0	0.0	0.0	0.0	0.0	0.0	423.8	0.0	0.0	0.0
NSMAF	"FAN, GRAMD5"	ENSG00000035681	"Neutral sphingomyelinase activation associated factor"	Q92636	8	58583504-58659844	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023067, HPA023148, HPA023151"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA023067: AB_1854653, HPA023148: AB_10670028, HPA023151: AB_1854654"	"unprognostic (1.09e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.86e-3)"	"unprognostic (2.69e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.03e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.44e-1)"	"prognostic unfavorable (4.61e-9)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.69e-1)"	19.3	18.9	13.3	19.2	23.5	8.9	22.7	19.5	14.8	15.2	16.8	11.3	6.0	11.0	17.9	11.5	16.1	12.7	13.1	17.3	12.8	10.9	9.9	6.7	17.7	27.2	13.4	11.7	15.5	20.9	25.6	16.3	15.6	12.9	14.9	17.9	12.7	14.1	15.9	20.3	22.4	16.9	22.3	12.1	20.9	16.8	8.4	11.1	43.8	16.3	11.2	25.0	19.2	17.9	4.8	14.5	15.4	7.2	6.4	8.7	4.5	13.3	13.0	5.9	8.3	22.6	18.4	10.2	10.7	23.9	15.0	14.1	7.2	8.4	16.2	9.0	16.9	15.6	10.7	10.0	8.6	17.1	18.0	5.5	30.3	8.1	8.1	28.7	13.2	21.1	12.4	13.8	10.8	41.6	12.4	14.9	15.0	13.0	11.9	16.9	10.0	27.7	10.7	10.5	10.7	5.1	10.5	8.7	4.6	8.4	10.7	5.5	7.0	9.0	3.4	9.8	8.2	8.3	16.6	13.7	14.9	9.0	19.9	10.9	2.2	1.1	12.8	21.9	10.4	9.4	8.3	7.2	4.8	6.8	5.3	7.0	4.8	7.2	7.1	14.5	4.6	5.1	4.8	15.4	6.4	3.6	5.0	8.7	4.5	13.3	23.5	19.5	14.8	12.8	10.9	13.4	11.7	12.9	11.1	8.9	5.1	13.2	8.6	16.4	8.7	13.7	2.5	2.7	11.4	8.7	3.9	10.5	3.3	6.7	0.2	11.3	6.9	0.0	7.5	7.1	11.3	7.8	27.7	3.4	16.5	30.2	13.8	5.5	29.2	1.5	15.3	27.7	10.1	10.0	8.7	6.0	6.9	7.0	12.0	3.7	5.7	6.5	9.8	1.6	3.2	15.6	7.8	17.3	9.9	8.9
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.6	8.3	17.4	13.9	6.5	9.4	17.5	12.5	8.7	16.5	15.2	12.7	12.6	20.4	13.5	7.9	6.6	13.9	18.9	11.7	18.0	15.9	26.1	9.8	14.2	6.5	11.2	19.3	15.6	7.6	9.3	14.7	16.6	7.9	10.8	12.4	25.6	12.6	10.8	11.4	14.9	9.6	26.8	11.0	14.9	18.8	21.7	13.1	10.0	10.3	15.4	13.5	18.9	28.9	17.1	15.5	13.8	17.6	10.4	13.2	8.6	15.3	23.1	8.3	18.1	21.7	8.4	15.7	13.7	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0	20.8	23.9	8.8	3.8	4.6	13.9	8.8	5.1	21.4	13.6	1.8	9.8	16.6	11.6	8.1	5.6	6.0	8.6	0.0	7.2	11.3	8.7	4.4	15.1	2.9	9.1	9.5	4.1	5.5	5.7	2.2	8.9	6.6	5.0	5.4	11.5	9.4	6.7	17.5	10.3	5.6	21.0	0.0	8.3	14.6	12.6	4.0	15.3	7.5	14.5	3.8
OSGIN2	"C8orf1, hT41"	ENSG00000164823	"Oxidative stress induced growth inhibitor family member 2"	Q9Y236	8	89901859-89927888	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 59.6;Early spermatids: 185.9;Late spermatids: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 17.0"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 57.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028515, HPA050595"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA028515: AB_10602014, HPA050595: AB_2681186"	"unprognostic (3.29e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.42e-3)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (3.91e-6)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.22e-3)"	"unprognostic (4.38e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.25e-2)"	15.2	7.5	12.5	7.8	13.9	40.4	16.8	9.6	17.5	7.6	13.3	26.4	6.0	6.8	26.1	6.1	11.7	8.1	14.2	11.2	14.2	13.4	14.7	16.2	15.7	9.1	13.7	13.0	15.9	7.8	53.5	25.2	6.5	18.2	9.1	8.6	8.3	8.6	7.3	13.2	7.6	8.7	17.1	25.3	9.0	7.5	20.5	14.7	7.1	12.9	8.0	8.9	11.1	8.5	3.0	1.5	17.0	1.4	2.0	2.5	1.3	12.2	12.0	3.0	6.1	6.7	4.9	4.0	8.8	16.9	8.1	7.9	5.6	11.7	8.4	18.0	4.5	10.1	4.5	5.7	6.9	12.7	12.1	4.6	12.8	4.7	3.0	11.4	6.4	8.0	5.7	9.1	9.4	7.8	7.0	9.9	11.1	7.4	15.0	5.8	9.5	11.1	4.3	1.5	12.3	6.4	4.9	4.5	7.2	12.2	9.5	2.8	7.1	6.5	57.5	10.6	5.4	11.7	9.6	6.7	8.9	8.2	7.3	8.0	13.9	11.9	9.2	14.8	7.9	6.2	17.0	1.4	5.8	1.7	0.9	2.4	3.0	2.5	1.5	1.5	1.8	2.1	2.3	10.3	2.0	1.1	1.1	2.5	1.3	12.5	13.9	9.6	17.5	14.2	13.4	13.7	13.0	18.2	14.7	59.6	15.0	11.9	5.9	5.4	7.8	11.6	20.4	10.7	13.6	7.0	2.0	6.5	8.3	12.6	185.9	5.6	2.6	0.0	13.9	6.9	9.4	6.7	16.2	15.8	14.2	3.2	9.2	15.4	18.3	163.7	11.5	10.8	6.8	7.2	4.6	23.0	11.2	3.5	11.7	11.9	5.2	12.9	6.2	12.2	5.9	3.8	1.4	5.3	5.2	5.2
OSMR	OSMRB	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.4;GAMG: 39.5;HSkMC: 47.5;U-2197: 38.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"	NA	NA		21000000	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	41.1	18.0	7.3	18.7	9.4	0.3	31.0	3.1	9.4	14.1	13.7	2.8	4.6	4.4	14.4	12.9	14.7	14.5	22.4	22.4	5.4	3.5	19.7	23.6	25.7	31.7	9.0	1.3	33.6	10.1	6.6	10.5	40.1	13.3	20.8	8.6	9.2	17.2	11.1	13.0	12.5	8.0	32.5	15.6	23.5	11.5	10.8	6.9	3.6	17.5	10.4	11.3	40.4	43.6	0.6	0.6	1.6	0.4	0.7	0.6	0.1	7.4	9.7	1.6	4.2	17.9	38.4	5.6	12.2	19.4	12.0	16.2	0.0	20.3	0.0	5.8	12.9	39.5	10.4	2.1	15.0	19.5	0.0	1.2	0.5	7.6	7.3	20.3	0.0	0.1	47.5	9.0	27.0	23.1	22.4	1.8	0.0	0.0	0.0	7.5	2.0	0.0	0.0	0.2	1.5	3.2	0.0	0.5	0.0	24.2	2.2	0.0	0.0	27.6	0.0	0.0	2.4	8.4	0.0	2.8	29.4	11.1	38.0	6.5	0.0	0.0	0.0	23.6	0.0	6.3	1.6	0.4	0.4	0.5	0.3	0.2	0.3	0.3	0.1	0.1	0.6	0.4	0.6	1.0	0.7	0.1	0.6	0.2	0.1	7.3	9.4	3.1	9.4	5.4	3.5	9.0	1.3	13.3	6.9	41.7	42.5	0.0	57.8	27.0	0.0	2.8	22.9	9.4	46.6	12.2	0.0	5.3	0.0	43.3	0.5	37.0	0.0	0.0	41.7	6.0	25.9	39.4	1.1	11.3	1.3	0.0	0.0	60.2	9.7	0.4	38.6	1.3	6.8	2.8	0.0	0.8	60.1	0.0	7.1	3.3	0.6	19.4	24.0	0.3	0.6	21.0	14.3	0.5	0.0	57.6
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694695-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 48.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	12.8	9.9	12.0	12.2	9.7	11.5	15.9	9.1	15.7	12.7	8.7	5.8	7.7	5.9	10.5	9.9	15.7	8.7	7.2	8.6	9.2	9.8	12.3	17.5	7.2	16.3	10.9	9.2	13.8	10.6	6.8	9.1	9.1	11.3	48.8	9.8	4.2	10.3	10.4	20.6	7.8	6.8	10.5	10.1	10.9	7.4	6.3	9.9	8.4	9.3	18.5	11.7	8.2	9.1	8.4	11.5	2.4	10.3	8.1	12.3	5.8	14.3	5.6	7.3	12.7	9.2	8.4	10.6	9.4	7.8	14.3	14.1	12.4	6.4	14.5	23.6	8.0	17.9	7.7	15.0	12.1	20.6	8.5	10.1	8.0	5.3	14.2	13.5	22.1	10.5	7.7	10.6	13.9	23.6	4.8	9.5	8.0	24.1	4.2	11.8	8.5	11.0	20.3	16.0	13.4	10.1	11.5	9.6	22.5	10.3	8.6	11.1	9.6	7.0	18.1	20.1	13.0	8.0	8.0	8.2	11.6	8.3	12.4	23.2	10.0	27.3	15.9	4.7	14.9	21.7	1.1	7.1	2.4	8.4	10.3	8.6	8.4	7.6	8.4	10.0	6.4	10.2	12.3	0.3	8.1	8.0	11.5	4.8	5.8	12.0	9.7	9.1	15.7	9.2	9.8	10.9	9.2	11.3	9.9	17.9	10.5	28.3	38.3	59.0	12.9	16.6	17.8	22.7	36.4	10.4	3.9	22.4	16.6	36.8	10.2	17.7	5.4	0.0	23.3	24.5	23.5	36.7	34.6	18.1	32.0	12.7	5.2	16.0	9.9	8.3	19.8	14.9	11.8	19.0	10.5	11.8	25.6	3.5	19.4	17.9	10.1	6.5	25.9	23.4	49.7	43.5	14.6	12.5	19.9	26.0
PFKFB4		ENSG00000114268	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4"	Q16877	3	48517684-48562015	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 26.0"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 36.2;Mucus-secreting cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 11.4;intermediate monocyte: 7.3;neutrophil: 21.6;non-classical monocyte: 12.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 21.6;monocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 22.9;U-87 MG: 36.5;WM-115: 31.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047719, HPA066058"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA047719: AB_2680129, HPA066058: AB_2685606"	"unprognostic (7.60e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.90e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.65e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.78e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.91e-8)"	"unprognostic (2.04e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.35e-2)"	2.0	2.2	4.0	3.9	4.9	12.7	2.1	6.3	6.3	2.6	17.1	8.6	3.0	17.8	2.1	18.5	6.4	1.5	1.8	1.4	4.2	5.2	3.6	1.7	3.8	6.3	7.4	2.7	3.5	18.9	4.1	5.1	9.5	6.9	3.3	3.5	3.3	2.5	2.0	4.8	3.3	24.0	2.5	5.3	10.0	1.2	26.0	5.2	0.4	1.6	3.6	2.6	4.9	4.2	0.2	2.7	21.6	12.2	0.2	0.5	2.1	5.0	1.5	3.6	3.3	1.2	1.8	7.1	2.5	4.3	5.2	12.6	2.5	1.8	2.2	2.4	1.9	12.4	1.4	1.5	4.4	4.6	1.5	1.2	5.1	3.3	2.7	1.0	0.9	2.3	1.8	6.6	8.3	0.8	22.9	1.2	2.9	1.7	1.9	4.1	1.1	0.3	7.1	2.2	1.0	3.4	0.4	1.7	2.3	2.0	4.7	1.0	2.2	2.7	1.2	9.9	3.7	2.8	2.2	0.3	5.3	2.1	0.6	15.3	8.8	1.9	1.3	36.5	1.8	31.7	0.0	6.5	11.4	0.2	7.3	0.1	0.2	0.3	0.0	2.7	0.1	0.5	0.1	21.6	0.2	12.2	0.3	0.0	2.1	4.0	4.9	6.3	6.3	4.2	5.2	7.4	2.7	6.9	5.2	0.0	2.2	0.0	0.3	2.9	5.0	0.6	0.0	1.4	1.2	0.0	2.0	11.1	0.0	2.0	2.6	0.4	1.7	0.0	1.3	36.2	1.5	0.4	1.1	0.0	5.3	6.4	4.1	1.8	11.0	2.0	0.9	4.4	1.7	0.0	11.8	3.6	2.9	0.3	0.7	0.0	4.3	0.0	0.8	0.5	0.5	1.5	4.6	0.0	1.5	0.0
PHLDA2	"BWR1C, HLDA2, IPL, TSSC3"	ENSG00000181649	"Pleckstrin homology like domain family A member 2"	Q53GA4	11	2928273-2929455	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 163.9"	"Cell type enhanced"	"Detected in many"	18	"Cytotrophoblasts: 3794.0;Syncytiotrophoblasts: 8329.2;Urothelial cells: 2915.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 83.8;PC-3: 68.1;SK-MEL-30: 53.5;WM-115: 73.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA003994			Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA003994: AB_1855311"	"unprognostic (1.90e-1)"	"unprognostic (3.13e-2)"	"unprognostic (9.93e-3)"	"unprognostic (6.16e-2)"	"unprognostic (4.28e-2)"	"unprognostic (8.01e-3)"	"prognostic unfavorable (4.22e-5)"	"unprognostic (1.24e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavorable (2.63e-6)"	"unprognostic (2.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.59e-1)"	3.8	1.1	0.5	3.6	0.7	1.4	7.7	0.3	1.4	5.6	7.9	0.5	1.7	5.9	2.3	5.5	20.3	2.4	15.6	1.5	0.5	1.9	4.8	3.7	3.9	0.8	1.3	0.5	1.8	4.6	1.2	1.2	163.9	1.9	8.0	1.4	0.8	5.3	2.0	0.8	9.6	7.4	1.9	1.0	1.8	11.1	1.0	0.5	0.2	3.5	24.7	15.1	6.1	8.7	1.5	8.2	0.0	4.9	0.0	3.9	1.5	9.4	8.4	0.3	0.1	0.1	1.7	9.1	21.0	5.3	3.0	2.2	3.4	18.7	0.0	10.3	2.3	6.9	11.7	0.0	8.3	0.3	83.8	2.8	0.0	4.5	2.1	6.9	0.0	5.0	2.8	3.8	2.5	2.0	1.7	2.5	0.0	1.8	0.1	1.2	29.8	0.0	1.4	3.4	4.7	68.1	0.0	0.0	5.7	6.1	2.9	0.9	0.0	6.7	4.6	53.5	0.4	1.4	0.8	13.9	6.7	3.6	9.4	7.1	0.1	0.1	0.0	5.5	1.4	73.4	0.0	4.9	0.0	0.7	3.0	0.8	1.5	3.9	0.9	8.2	0.0	1.0	0.2	0.0	0.0	0.6	0.0	1.4	1.5	0.5	0.7	0.3	1.4	0.5	1.9	1.3	0.5	1.9	0.5	17.9	37.7	0.5	1363.4	350.5	0.0	4.8	48.4	16.0	48.9	41.8	0.0	3794.0	8.3	172.2	2.1	8.7	316.4	0.0	128.2	1743.3	110.0	1372.9	82.9	3.4	356.1	0.0	189.0	11.6	9.2	0.4	3.4	47.2	97.8	17.2	122.2	0.0	313.5	273.8	2.8	0.3	0.1	51.8	311.1	0.5	4.5	599.1	8329.2	3.8	109.0	2915.8
PITX1	"BFT, POTX, PTX1"	ENSG00000069011	"Paired like homeodomain 1"	P78337	5	135027735-135034813	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 119.4;lymphoid tissue: 60.8;tongue: 58.8"	"Cell type enhanced"	"Detected in some"	27	"Basal glandular cells: 84.7;Glandular cells: 52.7;Urothelial cells: 214.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 73.6"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;HeLa: 33.0;K-562: 32.2;T-47d: 48.1"	"Not detected"	"Not detected"							HPA008743	Approved		Approved	Nucleoli		Yes	No			Nucleoli		"HPA008743: AB_1855413"	"unprognostic (1.84e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.26e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (5.80e-14)"	"unprognostic (6.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.98e-3)"	"unprognostic (4.97e-3)"	0.3	0.3	0.0	4.7	0.0	0.3	0.2	0.0	0.2	14.8	2.8	0.0	0.0	5.6	0.5	1.2	119.4	0.3	1.9	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	32.9	1.3	1.0	8.8	1.1	10.8	33.0	0.2	8.6	0.5	3.2	18.6	0.0	0.2	7.4	0.4	0.0	0.0	0.4	58.8	60.8	18.2	28.9	0.3	0.3	1.4	0.4	0.4	1.1	0.2	17.2	10.6	0.0	14.2	0.6	0.2	4.4	3.4	5.0	1.7	0.6	40.4	10.2	19.4	5.5	0.2	4.2	5.9	2.3	8.3	0.1	0.2	15.0	4.8	33.0	11.1	5.2	1.7	0.0	0.4	6.0	0.0	1.9	0.1	0.0	3.0	32.2	0.0	0.5	5.3	0.1	3.8	0.0	1.5	9.5	5.7	0.3	0.3	0.2	5.4	6.6	0.0	15.1	8.2	0.0	0.1	48.1	1.1	0.6	1.9	4.8	1.0	5.3	0.0	0.0	12.7	2.5	0.1	0.0	1.4	0.3	0.1	0.9	0.3	0.5	0.3	0.6	1.1	0.2	0.3	0.3	1.0	0.7	0.4	0.4	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	84.7	1.1	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	3.4	0.0	0.3	0.0	0.4	2.0	0.9	52.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.4	0.3	0.0	0.0	0.0	0.3	0.0	9.9	0.3	0.0	0.0	2.0	0.0	1.4	1.4	4.1	5.9	6.4	0.0	0.6	214.7
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Group enriched"	"Detected in many"	5	"B-cells: 62.6;granulocytes: 59.1;Hofbauer cells: 195.0;Kupffer cells: 185.4;Macrophages: 211.6;monocytes: 179.5;T-cells: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 93.6;HL-60: 21.1;HMC-1: 35.8;NB-4: 31.4;THP-1: 36.6;U-266/84: 24.3;U-698: 24.9;U-937: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli		NA	NA		970000000	Nucleoli		"HPA031838: AB_10602146, HPA057341: AB_2732609"	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.6	0.0	0.0	0.0	21.1	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	10.3	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	1.4	24.3	24.9	0.0	58.0	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7	17.9	30.6	62.6	0.1	5.8	0.0	1.7	0.0	24.1	28.4	1.8	0.0	1.0	0.0	0.1	1.4	3.1	0.0	0.0	0.5	1.3	6.1	0.1	59.1	0.9	195.0	0.0	0.0	4.9	185.4	4.5	0.6	211.6	16.9	179.5	0.0	0.0	0.1	0.0	0.4	0.6	0.0	12.9	2.6	0.9	0.7	5.8	2.2	116.7	0.0	0.1
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli		NA	NA			Nucleoli		"HPA066194: AB_2732742"	"prognostic unfavorable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (1.26e-6)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.7	7.7	8.4	7.7	2.9	2.1	5.6	10.9	9.2	11.4	8.5	7.9	8.3	9.0	15.8	7.9	5.5	8.5	24.2	10.8	12.3	6.5	10.2	17.8	6.1	5.3	1.3	9.4	11.3	1.8	2.0	12.6	5.0	3.5	8.9	4.3	9.7	8.1	10.7	10.1	13.6	4.8	6.3	14.9	10.6	11.3	4.9	6.5	8.3	6.8	20.0	4.7	5.0	8.6	3.8	5.0	11.6	3.5	12.0	10.0	7.2	12.6	21.6	8.1	7.6	19.3	7.9	10.2	8.8	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2	3.0	3.8	5.1	4.8	3.3	7.8	2.8	0.0	2.7	4.5	5.2	0.0	3.2	5.0	9.5	9.8	2.9	1.3	0.0	5.0	2.8	2.7	3.5	1.1	5.5	3.0	1.6	0.0	3.1	1.6	1.8	4.9	3.2	0.0	9.0	1.6	3.1	6.4	0.0	4.2	7.8	9.6	6.5	2.7	3.9	15.7	2.0	2.5	1.9	2.7	3.9
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Supported	Nucleoli		NA	NA			Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.3	11.3	29.9	19.9	4.0	8.5	16.2	14.5	9.7	22.0	18.3	19.8	9.5	22.0	18.4	10.2	29.0	11.6	35.3	24.2	25.2	18.3	29.5	26.0	7.4	26.1	13.4	22.2	10.9	6.3	11.5	16.9	31.6	8.1	19.6	21.3	48.8	10.7	15.8	13.6	26.4	10.2	19.8	27.5	15.3	21.3	26.2	19.7	13.0	10.1	31.8	16.8	9.7	10.4	19.1	23.0	15.2	18.9	11.9	17.0	15.7	12.9	24.2	11.8	30.6	40.1	5.4	41.2	32.3	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0	6.0	6.9	6.7	16.2	2.7	14.1	40.3	7.6	20.1	7.9	5.2	3.9	50.9	19.9	22.9	21.9	9.2	2.6	0.0	17.8	54.4	8.4	9.5	10.4	6.8	25.9	15.9	3.5	3.7	2.8	8.5	6.4	9.5	6.8	11.8	8.5	25.1	18.1	7.0	11.7	10.2	10.5	6.5	8.9	14.4	49.0	4.0	21.2	7.5	10.3	8.6
PPP1R7	sds22	ENSG00000115685	"Protein phosphatase 1 regulatory subunit 7"	Q15435	2	241149576-241183652	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 735.0;Late spermatids: 1235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034500, HPA034501"	Supported		Approved	Nucleoli		NA	NA		650000	Nucleoli		"HPA034500: AB_2674192, HPA034501: AB_10670965"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.07e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.23e-1)"	21.5	21.9	39.2	19.4	82.1	22.2	19.7	25.0	40.5	19.0	24.8	16.4	18.8	22.2	18.9	24.8	31.5	32.2	20.5	36.9	31.3	23.3	24.9	28.8	20.4	27.2	23.7	35.2	16.4	22.8	21.9	18.4	17.3	23.5	37.9	25.3	17.6	22.9	22.2	46.4	24.2	22.7	21.3	20.8	17.6	21.8	57.3	29.4	21.2	25.5	26.1	29.6	24.4	25.0	31.4	37.5	48.5	41.0	32.8	53.3	37.4	31.3	19.0	21.6	27.3	42.9	43.1	29.9	34.7	31.8	24.0	34.0	10.3	40.2	16.2	10.4	29.7	36.1	30.9	35.4	32.8	36.9	42.0	34.9	28.3	31.0	40.8	27.7	39.0	29.8	33.2	26.0	28.3	21.0	32.7	35.5	33.4	28.5	24.0	56.0	41.7	34.8	30.1	29.6	50.2	18.2	24.2	56.3	32.7	44.6	31.8	29.4	23.4	18.6	43.8	31.7	25.4	26.1	42.5	34.9	21.8	20.7	40.9	27.9	25.6	15.4	43.8	61.1	41.7	28.6	40.4	39.8	48.5	32.1	40.0	33.7	31.4	38.4	37.7	37.5	28.8	29.8	34.5	31.4	32.8	41.0	22.4	53.3	37.4	39.2	82.1	25.0	40.5	31.3	23.3	23.7	35.2	23.5	29.4	53.6	46.2	73.1	40.9	24.6	40.6	88.8	48.4	119.1	70.5	41.8	15.7	79.0	102.8	76.7	735.0	40.9	60.8	0.0	127.1	78.3	37.5	46.6	56.7	41.4	87.4	30.2	24.6	27.6	40.5	1235.7	47.2	67.7	82.7	65.9	50.2	55.2	81.2	63.3	63.3	96.6	36.4	71.1	54.5	161.9	125.6	33.2	59.8	59.5	47.6	47.3
PRR29	"C17orf72, DKFZp761M2312, FLJ11724"	ENSG00000224383	"Proline rich 29"	P0C7W0	17	63998351-64004304	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 17.9;fallopian tube: 48.7;testis: 23.5"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 164.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.8;REH: 7.0;TIME: 5.6"									HPA051264			Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA051264: "	"unprognostic (2.05e-2)"	"unprognostic (6.46e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.22e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.30e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.98e-3)"	0.9	0.5	3.3	0.8	7.6	0.6	0.9	0.1	2.1	4.0	0.5	8.3	0.4	0.6	1.0	17.9	0.6	48.7	1.0	0.7	5.6	5.5	0.6	0.6	7.3	0.7	1.6	0.8	8.1	0.5	0.9	5.8	0.7	15.2	0.6	0.4	0.2	0.9	0.9	0.6	0.5	0.5	0.6	1.1	2.5	0.5	23.5	1.0	0.0	2.5	0.0	0.7	1.0	0.0	1.0	0.7	3.1	1.8	1.0	3.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.2	0.0	0.0	0.4	0.0	6.8	0.0	0.7	0.0	1.5	0.0	0.1	0.5	0.2	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.2	1.9	1.0	0.0	0.0	0.0	2.4	0.0	0.2	1.4	0.2	7.0	0.1	2.9	0.5	0.0	0.4	2.1	0.0	0.3	0.4	1.1	1.1	0.0	5.6	0.2	2.4	0.7	0.2	0.7	0.2	0.5	0.9	0.3	0.0	3.1	0.9	0.0	2.0	1.8	0.4	0.7	1.7	1.0	0.7	1.0	3.0	1.7	0.8	1.0	1.7	0.1	1.1	1.6	3.3	7.6	0.1	2.1	5.6	5.5	1.6	0.8	15.2	1.0	0.0	3.2	0.5	0.0	0.0	0.0	0.1	0.0	164.6	18.2	3.5	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	21.8	1.4	0.0	0.2	0.0	0.0	0.0
PUM3	"HA-8, hPUF-A, KIAA0020, PEN, PUF6, XTP5"	ENSG00000080608	"Pumilio RNA binding family member 3"	Q15397	9	2720469-2844241	"Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 99.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 73.4;HEL: 71.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002353	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA002353: AB_1852266"	"unprognostic (1.39e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (4.89e-5)"	"unprognostic (2.02e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (2.44e-3)"	"unprognostic (8.44e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.43e-2)"	19.4	17.0	11.5	19.0	15.2	14.8	22.1	15.6	17.7	18.9	16.9	8.3	9.8	11.2	17.1	10.6	29.3	15.7	10.5	15.1	16.7	5.9	23.2	18.4	18.6	18.9	14.0	14.3	24.4	17.8	11.5	23.1	15.9	15.8	18.0	17.3	6.1	20.7	10.3	21.0	16.4	13.2	19.5	18.2	17.8	14.2	13.8	14.9	15.4	15.1	14.5	18.9	20.1	21.6	15.3	13.7	3.8	12.8	15.9	18.4	7.8	17.0	12.6	10.6	10.8	8.9	9.5	12.1	15.9	8.4	16.4	15.4	9.5	8.0	18.9	3.7	10.9	9.8	8.6	19.2	13.7	21.5	73.4	6.8	71.5	12.7	11.4	11.9	31.5	13.4	7.7	6.1	13.3	19.1	7.5	12.1	12.4	7.4	8.6	14.3	7.7	15.9	25.7	27.2	13.1	5.6	18.8	8.3	8.1	11.1	11.5	11.0	10.6	9.6	8.9	8.6	12.4	5.6	17.1	11.5	11.1	9.1	10.6	21.2	4.0	6.5	26.6	8.4	11.5	8.0	3.8	9.2	2.7	13.2	12.8	18.4	15.3	13.7	13.2	12.1	13.5	15.3	14.8	1.3	15.9	10.4	13.7	10.0	7.8	11.5	15.2	15.6	17.7	16.7	5.9	14.0	14.3	15.8	14.9	44.7	39.5	24.8	31.5	0.0	23.8	0.0	20.4	58.9	76.2	22.7	9.8	29.4	39.7	30.6	3.5	15.7	3.1	0.0	22.9	37.0	25.8	19.6	16.3	15.7	19.1	25.4	8.2	20.3	14.3	2.2	43.7	23.0	0.0	35.1	10.7	18.3	24.5	7.0	21.5	99.1	25.6	0.0	0.0	32.5	43.2	0.0	29.3	8.7	16.7	27.1
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966371	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA038860: AB_10697400, HPA058732: AB_2683801"	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	15.4	18.4	19.9	23.5	26.1	23.8	17.1	25.0	26.7	13.7	15.4	27.5	16.0	14.7	17.7	15.1	15.7	15.1	13.0	14.3	19.4	12.6	16.5	15.7	15.2	22.1	22.4	16.2	25.5	21.3	22.0	16.6	16.9	19.4	19.0	15.8	16.0	16.1	16.2	20.0	16.3	16.5	19.6	14.5	19.1	16.7	17.3	26.3	16.8	26.7	14.4	21.5	17.1	21.7	8.1	6.7	1.4	11.9	7.9	9.1	4.8	7.1	14.4	8.6	16.8	8.7	7.0	13.1	13.0	10.2	14.7	10.8	19.2	10.1	12.8	8.1	11.0	10.8	10.2	20.3	12.5	11.6	23.2	11.8	27.6	14.2	18.4	6.6	20.8	13.2	8.6	8.3	17.9	6.5	9.4	10.7	10.1	29.6	5.3	9.1	10.7	11.7	15.7	18.9	7.2	12.4	15.6	8.3	11.1	10.0	14.0	10.4	8.3	11.6	16.9	7.9	7.5	18.5	6.0	12.0	9.7	11.9	8.3	7.9	9.7	7.2	12.9	13.0	14.9	12.2	0.0	4.9	1.4	9.1	8.8	6.9	8.1	6.4	7.4	6.7	7.0	5.2	7.1	0.3	7.9	11.9	4.6	5.5	4.8	19.9	26.1	25.0	26.7	19.4	12.6	22.4	16.2	19.4	26.3	14.9	8.1	9.3	11.1	12.2	9.7	17.6	7.6	20.1	12.5	10.4	7.9	8.8	1.7	9.6	4.9	10.8	4.8	0.0	11.2	7.5	8.9	11.8	14.0	6.4	11.0	6.4	8.6	3.1	6.3	6.5	10.0	9.5	3.3	21.6	7.3	4.9	11.4	6.2	6.7	7.5	13.5	0.0	12.2	15.6	13.2	10.0	9.5	11.4	7.3	11.2
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		Yes	No			Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.6	20.6	12.5	35.7	8.9	5.7	17.1	17.2	7.1	15.6	17.0	17.1	16.4	24.8	9.4	7.8	22.8	12.7	18.3	14.6	20.3	12.4	17.6	24.9	14.4	15.7	7.9	31.3	22.4	6.4	9.6	20.7	12.5	5.9	14.4	13.8	46.5	14.5	12.1	15.1	22.4	17.9	23.8	12.9	16.2	17.8	15.0	23.8	7.6	12.7	14.0	17.0	22.2	37.2	11.8	15.6	9.5	9.6	13.8	22.7	11.8	20.1	20.8	15.0	12.8	43.0	14.9	26.5	24.4	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4	14.9	32.7	12.7	12.1	14.3	55.3	21.5	5.1	21.4	38.7	12.2	88.4	17.7	21.6	15.9	2.1	18.8	6.2	0.0	19.6	22.7	16.4	9.7	34.8	12.8	16.8	38.1	10.9	7.4	14.3	1.3	25.6	14.5	5.0	13.6	13.8	23.3	15.5	7.0	19.4	12.9	52.9	6.5	21.7	41.1	51.3	12.7	15.6	16.0	14.8	10.9
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85342088-85354620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 86.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 209.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA007961: AB_1079802, HPA046513: AB_2679680"	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	65.7	24.8	7.7	9.8	9.1	0.9	35.6	5.6	9.3	7.4	46.5	12.4	12.7	49.0	6.8	12.3	16.7	5.0	17.7	7.3	7.4	5.7	20.6	51.9	7.2	5.1	10.2	7.7	5.5	11.5	13.1	3.5	5.7	8.9	10.1	22.6	10.0	12.5	7.6	24.3	14.3	86.1	7.0	12.7	4.0	18.2	9.2	10.1	3.5	27.2	13.9	9.3	9.9	9.0	3.8	5.6	5.3	10.0	6.5	9.2	4.1	16.2	9.4	5.5	12.7	65.6	12.3	7.1	11.9	14.7	7.2	10.2	6.5	11.4	5.7	9.8	9.4	5.8	13.6	7.3	20.7	7.1	7.0	5.0	2.8	7.8	15.9	15.8	5.4	6.3	16.1	28.4	9.3	12.4	16.8	12.0	5.0	2.9	13.7	13.5	3.4	3.9	2.8	1.7	16.4	11.6	2.5	10.8	7.4	12.8	9.5	2.6	4.4	10.0	19.1	32.3	3.8	9.0	0.9	9.4	8.2	4.5	7.6	6.2	7.4	6.9	2.3	10.0	6.5	5.6	0.0	5.1	2.4	7.0	5.5	9.2	3.8	5.6	8.8	5.6	2.5	3.8	4.0	5.3	6.5	10.0	4.0	5.8	4.1	7.7	9.1	5.6	9.3	7.4	5.7	10.2	7.7	8.9	10.1	26.8	23.5	2.2	8.5	10.1	3.5	18.5	20.4	9.4	10.3	12.2	17.7	9.6	0.0	19.1	27.2	9.2	209.6	0.0	31.4	5.6	6.6	11.3	10.4	39.3	8.7	11.1	10.4	8.0	9.9	41.4	13.6	7.5	28.7	9.0	43.9	8.2	29.0	59.4	11.7	15.6	4.3	0.0	7.8	2.6	3.0	13.0	7.1	8.9	33.1	8.4
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.5"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 175.4;Spermatocytes: 283.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA013739			Approved	Nucleoli		NA	NA			Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favorable (2.57e-4)"	"unprognostic (2.60e-1)"	7.9	6.2	2.8	5.3	4.3	3.8	4.2	5.1	3.7	3.1	4.0	2.4	3.7	5.3	2.7	8.1	4.6	3.2	3.1	4.1	3.1	2.2	4.7	12.0	5.0	4.4	2.9	3.1	3.5	7.5	4.7	6.1	4.4	3.4	4.5	4.8	4.2	5.1	3.0	6.7	2.7	7.6	3.0	3.4	4.1	3.9	45.5	3.0	5.9	6.1	4.3	6.0	5.1	3.7	9.5	10.1	20.2	17.1	8.9	7.7	7.9	4.8	2.2	2.3	3.1	7.6	5.7	4.5	6.2	3.3	4.9	6.0	6.9	1.9	7.2	10.4	5.2	11.1	5.6	7.3	4.7	8.5	6.8	7.9	6.1	5.8	6.2	5.7	9.4	9.4	6.3	2.5	4.6	2.0	2.5	4.9	1.7	17.4	4.5	4.1	6.3	3.8	4.5	0.9	6.6	5.1	5.2	17.5	4.2	3.9	3.5	1.4	2.7	8.9	2.2	12.4	3.2	10.3	17.9	3.5	9.5	8.4	5.5	5.3	6.5	18.1	4.3	6.6	5.3	4.7	17.3	11.8	20.2	5.6	13.9	7.7	9.5	5.2	6.3	10.1	6.1	6.8	6.1	5.7	8.9	17.1	6.7	6.5	7.9	2.8	4.3	5.1	3.7	3.1	2.2	2.9	3.1	3.4	3.0	0.0	6.1	15.9	13.3	10.1	7.7	5.6	2.5	16.0	6.8	8.7	19.6	29.6	5.0	12.0	175.4	7.8	14.4	0.0	12.5	30.4	15.3	14.5	18.5	27.2	40.4	17.5	4.1	11.6	25.1	60.1	8.3	27.8	16.9	36.9	7.6	4.5	12.5	19.3	11.0	8.6	6.8	19.4	8.6	283.8	42.4	8.4	24.1	16.0	10.1	7.2
RPF1	BXDC5	ENSG00000117133	"Ribosome production factor 1 homolog"	Q9H9Y2	1	84479259-84497790	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024642	Supported		Supported	Nucleoli		No	No			Nucleoli		"HPA024642: AB_1856428"	"unprognostic (1.56e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.63e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.71e-1)"	20.9	20.4	21.3	25.1	36.2	42.7	26.3	14.8	24.7	21.3	24.8	12.8	18.8	18.8	25.5	27.4	26.0	20.8	18.2	39.8	17.9	16.5	33.1	33.8	21.3	27.2	16.7	15.1	23.9	21.3	16.8	25.7	19.8	16.0	23.7	24.0	14.1	20.8	26.2	56.8	22.1	22.7	20.8	16.6	33.9	22.8	31.0	20.3	31.8	29.3	27.9	30.2	30.0	23.1	36.9	23.1	29.2	26.0	31.8	33.9	26.1	18.9	13.4	17.0	14.1	13.3	17.7	19.2	19.6	17.3	25.6	22.8	10.1	8.2	14.6	22.1	15.4	42.0	14.4	25.4	20.1	28.3	21.0	26.7	36.8	15.1	17.4	18.4	35.3	12.1	14.0	30.0	26.7	19.0	14.6	20.4	27.7	35.5	18.8	22.3	9.9	33.2	23.8	42.3	19.5	29.9	21.4	27.2	11.8	24.3	22.3	21.4	19.9	11.4	24.4	46.7	16.3	13.8	24.2	14.0	19.3	19.2	30.4	40.4	13.0	15.3	32.3	9.0	31.9	17.2	29.2	21.3	19.6	26.6	24.6	29.3	36.9	30.4	26.9	22.5	31.0	33.8	33.9	8.9	31.8	26.0	23.1	31.3	26.1	21.3	36.2	14.8	24.7	17.9	16.5	16.7	15.1	16.0	20.3	35.7	39.9	29.5	37.1	30.8	16.6	33.9	28.1	56.2	31.8	15.7	15.7	30.8	63.0	50.8	38.7	32.2	14.2	0.0	55.7	26.7	25.8	24.7	62.5	32.6	39.0	7.9	32.1	25.2	28.4	6.4	30.2	41.3	27.0	25.2	25.0	24.4	43.8	28.1	32.9	47.6	20.8	45.3	26.9	66.1	60.2	28.5	23.0	49.8	33.6	38.2
RPP38		ENSG00000152464	"Ribonuclease P/MRP subunit p38"	P78345	10	15097180-15139818	"Enzymes, Predicted intracellular proteins, Ribosomal proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 439.8;Late spermatids: 144.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045128, HPA050398"	Approved		Supported	Nucleoli		NA	NA			Nucleoli		"HPA045128: AB_2797230, HPA050398: AB_2732560"	"unprognostic (1.75e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.46e-4)"	"unprognostic (1.41e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (6.13e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.11e-2)"	"prognostic favorable (2.89e-6)"	13.1	12.2	12.4	10.7	13.6	9.7	18.3	22.4	12.4	13.6	16.7	12.0	15.8	14.4	15.7	16.1	15.2	18.2	10.3	10.0	11.6	10.2	17.4	21.6	12.5	16.3	15.0	10.0	14.4	16.8	11.3	16.0	17.4	12.7	18.4	15.7	11.7	17.1	14.9	20.9	14.8	17.9	14.3	11.5	16.7	13.5	38.6	12.7	18.8	19.8	13.9	18.5	13.4	13.6	31.0	25.7	23.4	24.5	18.6	31.4	20.2	21.0	15.9	8.8	11.2	11.9	12.2	15.4	10.2	7.7	16.0	16.5	16.0	22.2	17.7	11.0	9.6	13.3	19.7	17.5	17.7	14.8	13.4	15.9	18.2	9.7	14.1	25.5	10.2	15.3	14.5	24.5	13.1	11.6	12.5	12.8	18.0	20.9	12.6	12.2	17.3	18.3	11.2	10.1	26.3	7.8	15.0	8.8	21.9	20.5	8.3	8.3	10.5	14.1	24.5	28.2	14.9	21.9	16.5	11.0	7.5	12.9	15.7	13.4	17.6	18.7	24.0	14.6	12.5	7.0	8.5	24.5	23.4	25.6	23.7	25.1	28.8	26.2	31.4	25.3	31.0	30.6	27.8	8.3	18.6	18.6	25.7	22.0	20.2	12.4	13.6	22.4	12.4	11.6	10.2	15.0	10.0	12.7	12.7	14.9	15.8	18.2	26.3	27.9	13.0	6.5	7.6	107.1	38.7	8.7	5.9	26.5	23.2	28.9	439.8	16.8	18.2	0.0	29.4	37.0	16.2	26.9	12.7	24.6	21.7	7.9	12.7	14.7	16.5	144.4	21.9	21.4	8.5	14.4	19.9	14.9	25.8	21.0	18.7	25.9	29.8	12.9	11.3	28.6	38.0	31.6	26.9	20.8	20.5	39.4
RRS1	KIAA0112	ENSG00000179041	"Ribosome biogenesis regulator homolog"	Q15050	8	66429028-66430733	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055549, HPA060937"	Approved		Supported	Nucleoli		Yes	No			Nucleoli		"HPA055549: AB_2682846, HPA060937: AB_2684390"	"unprognostic (7.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.84e-3)"	"unprognostic (4.93e-3)"	"unprognostic (2.82e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-2)"	"unprognostic (8.35e-3)"	12.0	11.2	8.7	14.1	12.4	7.0	9.9	8.5	9.8	8.5	9.6	7.1	7.2	10.3	13.4	6.6	12.2	11.2	9.8	9.6	8.5	7.5	9.5	18.0	6.7	14.6	11.5	7.9	19.0	41.4	8.3	5.8	7.6	11.1	9.0	7.1	6.4	9.8	9.7	31.7	10.2	7.7	14.0	7.8	9.5	12.0	4.9	9.9	8.6	7.5	19.2	11.5	13.7	13.1	6.8	15.2	0.6	11.8	11.2	17.8	6.8	22.8	28.9	5.9	12.5	6.4	5.2	9.6	14.4	6.4	11.2	8.3	12.9	15.2	31.1	5.0	7.6	15.8	21.5	14.5	16.4	12.4	17.0	24.5	24.7	8.7	22.8	9.5	14.6	13.1	6.8	13.3	12.3	16.5	4.6	7.2	9.5	21.5	13.2	8.1	26.5	29.1	26.7	38.6	25.8	34.0	6.2	7.6	12.9	15.6	18.9	8.1	18.0	7.0	11.7	16.0	6.4	20.2	13.1	12.4	20.9	18.7	17.5	33.2	23.8	21.2	24.0	9.7	23.2	14.1	0.0	8.9	0.6	10.0	11.8	17.8	6.8	12.7	11.7	15.2	6.7	11.9	13.6	0.3	11.2	7.2	7.1	9.1	6.8	8.7	12.4	8.5	9.8	8.5	7.5	11.5	7.9	11.1	9.9	29.8	15.2	9.7	26.7	62.2	9.6	27.1	2.5	12.0	25.0	12.2	11.8	18.5	10.0	21.9	0.1	14.2	1.9	0.0	24.3	16.0	12.9	12.3	7.0	13.9	18.3	6.4	6.4	11.6	9.1	0.8	17.5	10.2	21.9	2.8	12.4	7.2	19.3	7.0	16.3	20.6	11.3	19.4	31.4	5.7	14.0	52.2	32.3	20.0	17.7	24.5
RSPH14	RTDR1	ENSG00000100218	"Radial spoke head 14 homolog"	Q9UHP6	22	23059415-23145021	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 15.3;testis: 24.8"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 53.5;Early spermatids: 109.2;Late spermatids: 198.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in many"		"GAMG: 6.5;RPTEC TERT1: 6.9;U-266/70: 7.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA018420, HPA050425"	Approved		Uncertain	Nucleoli		NA	NA			Nucleoli		"HPA018420: AB_1856496, HPA050425: "	"unprognostic (8.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.31e-2)"	"unprognostic (7.28e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (5.18e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.73e-2)"	0.8	3.0	4.8	0.5	6.8	0.4	0.5	1.2	8.8	1.4	0.7	2.6	0.9	0.4	1.3	4.9	0.6	15.3	1.8	0.3	4.7	4.7	9.3	0.3	1.8	0.5	2.9	3.3	5.5	0.6	0.9	3.1	0.4	6.4	1.1	0.5	1.0	1.0	2.4	0.9	1.6	0.4	0.6	1.6	0.4	0.8	24.8	1.6	0.0	2.7	0.0	0.5	0.6	0.3	0.1	0.0	10.8	2.0	0.2	0.3	0.6	0.4	3.9	3.5	3.3	0.0	1.6	0.2	0.0	0.8	0.7	0.6	0.7	1.2	0.8	1.2	0.0	6.5	0.1	0.2	0.0	0.0	0.0	0.2	0.4	0.2	1.5	0.2	0.2	1.7	0.0	0.4	0.6	0.0	2.0	0.0	1.4	0.1	1.7	0.0	0.5	0.8	0.6	0.0	1.0	0.1	0.2	0.1	3.7	6.9	0.0	4.5	2.1	0.1	0.1	0.2	0.2	0.7	0.8	0.0	3.1	0.8	0.2	0.0	7.9	3.0	2.2	2.5	0.4	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	10.8	0.2	2.0	0.0	0.1	0.6	4.8	6.8	1.2	8.8	4.7	4.7	2.9	3.3	6.4	1.6	0.0	0.0	0.0	0.6	0.0	0.8	0.0	2.5	53.5	6.8	0.0	3.9	0.0	6.6	0.7	109.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	11.1	0.0	0.6	0.0	198.9	2.0	0.0	0.0	0.0	0.0	3.1	0.3	0.0	1.8	13.9	4.5	0.0	0.0	21.7	7.5	0.0	0.0	0.0	0.0	0.3
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 401.2;Enterocytes: 467.1;Hepatocytes: 434.3;Paneth cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.5;HEL: 28.5;HSkMC: 19.8;OE19: 23.2;SK-BR-3: 68.7"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		NA	NA		57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.3	8.0	0.4	38.5	15.4	2.0	1.6	0.8	0.8	1.6	4.3	1.3	0.0	7.4	2.6	0.0	0.0	0.0	0.1	0.6	0.0	3.7	28.5	14.4	6.9	8.1	0.0	0.0	19.8	0.2	1.3	0.0	0.1	4.8	0.0	2.8	0.0	2.0	3.2	0.0	0.0	6.4	23.2	8.1	0.0	0.4	0.1	1.8	0.0	0.1	0.1	0.0	68.7	0.0	6.8	11.8	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0	273.9	401.2	14.3	27.8	9.6	0.2	107.6	81.5	93.7	100.1	5.2	0.0	2.2	97.8	10.9	0.6	13.2	467.1	280.4	7.9	1.9	45.2	28.8	26.5	434.3	11.9	0.0	149.0	21.5	23.4	2.0	61.5	8.5	32.1	0.0	88.1	35.2	8.1	327.6	76.0	115.0	1.0	51.8	66.0	0.0	0.2	8.7	3.3	6.9	282.5	68.5
SERTAD3	RBT1	ENSG00000167565	"SERTA domain containing 3"	Q9UJW9	19	40440844-40444705	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068262			Approved	Nucleoli		NA	NA			Nucleoli		"HPA068262: AB_2685965"	"unprognostic (1.56e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.50e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.66e-3)"	28.3	13.0	5.7	16.8	7.1	10.8	18.6	3.7	6.9	29.3	31.5	13.0	22.0	12.3	24.6	22.2	29.6	18.8	24.9	21.1	5.8	5.7	21.4	19.6	23.6	12.3	8.8	4.5	33.1	8.0	8.8	14.1	49.1	6.6	24.8	14.2	13.6	15.7	25.1	32.1	13.5	25.2	18.9	7.9	21.4	18.6	16.6	6.8	7.8	25.6	24.2	17.3	31.8	18.3	14.4	24.8	28.7	20.6	7.8	7.7	12.2	15.5	30.2	10.6	13.8	11.9	18.3	14.7	12.7	17.2	18.2	15.8	10.9	12.2	7.6	5.7	16.4	11.1	5.7	10.7	12.4	10.3	8.5	4.7	5.0	9.9	9.3	14.1	1.2	16.1	16.1	17.1	11.3	8.2	14.8	14.8	3.5	15.0	5.1	14.4	23.3	3.1	6.1	5.6	13.5	7.4	4.6	6.5	6.2	14.4	12.3	1.5	6.6	10.8	18.9	9.5	17.0	16.5	12.6	12.3	15.6	12.5	12.0	10.0	8.7	4.6	6.5	12.4	5.5	6.9	12.2	20.6	22.0	7.1	20.4	7.1	14.4	7.7	7.6	23.0	12.7	5.7	6.8	28.7	7.8	17.1	24.8	6.0	12.2	5.7	7.1	3.7	6.9	5.8	5.7	8.8	4.5	6.6	6.8	8.9	11.8	24.9	34.2	41.0	3.3	9.2	10.2	9.4	5.7	22.7	3.9	75.5	26.6	27.3	5.4	27.8	37.4	0.0	26.8	74.2	58.2	42.4	20.7	6.0	31.4	3.2	47.1	31.9	20.3	5.1	26.4	36.8	32.1	30.7	43.9	19.3	27.7	44.4	28.7	18.2	0.5	58.2	28.6	11.4	13.0	37.6	156.8	15.0	27.5	37.6
SETMAR	metnase	ENSG00000170364	"SET domain and mariner transposase fusion gene"	Q53H47	3	4303304-4317567	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Methyltransferase, Multifunctional enzyme, Nuclease, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA057999			Supported	Nucleoli		NA	NA			Nucleoli		"HPA057999: AB_2683574"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.61e-6)"	"unprognostic (5.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-3)"	14.1	6.2	7.3	7.2	9.2	3.7	14.2	6.9	8.5	12.5	6.5	6.2	5.2	4.3	19.4	7.6	7.2	12.5	8.2	6.3	6.6	4.3	10.1	5.3	5.1	6.5	9.1	8.7	19.4	9.8	5.7	7.4	5.6	6.5	13.9	6.9	5.7	11.9	10.0	7.7	7.3	5.7	16.8	7.2	5.0	6.0	7.3	10.8	13.1	11.5	8.3	4.4	11.3	13.3	3.8	1.6	1.9	3.3	0.5	5.3	1.5	3.0	2.7	8.2	1.7	19.7	6.5	8.3	3.3	1.0	3.3	3.1	2.8	2.3	8.0	3.5	1.8	6.0	2.6	7.2	5.0	3.6	5.4	6.2	10.0	4.9	4.5	2.3	4.7	4.2	7.7	3.9	2.4	0.8	3.0	4.8	9.1	6.6	3.0	5.1	4.1	7.0	3.0	8.0	1.9	4.7	8.3	8.1	3.3	3.1	4.2	6.5	9.6	4.0	5.0	4.3	5.4	4.8	2.7	3.1	4.9	6.9	4.1	4.3	4.0	9.5	19.8	1.8	5.4	4.1	1.9	1.1	1.3	2.3	3.3	2.0	2.9	2.7	2.9	1.0	3.8	4.5	5.3	0.2	0.5	1.9	1.6	1.7	1.5	7.3	9.2	6.9	8.5	6.6	4.3	9.1	8.7	6.5	10.8	0.0	5.3	2.7	7.6	2.2	5.2	5.9	5.1	9.4	13.6	0.0	0.0	20.4	11.6	10.1	0.6	6.8	2.3	0.0	11.6	12.2	7.4	3.2	1.1	2.5	5.2	0.0	3.5	3.7	1.0	0.9	8.9	1.8	0.0	4.6	2.6	4.1	6.6	5.1	12.4	4.3	2.8	6.5	5.7	4.6	5.1	0.5	13.6	1.3	5.6	3.1
SMKR1		ENSG00000240204	"Small lysine rich protein 1"	H3BMG3	7	129502479-129512932	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"testis: 65.7"	"Group enriched"	"Detected in many"	36	"Early spermatids: 1715.8;Late spermatids: 4654.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"B-cells: 2.9;NK-cells: 1.3;T-cells: 3.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 12.8;SCLC-21H: 22.5"					"Low region specificity"	"Detected in all"			HPA078358			Approved	Nucleoli		NA	NA			Nucleoli		"HPA078358: AB_2686883"	"unprognostic (5.08e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.13e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.24e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.72e-6)"	"unprognostic (1.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.67e-2)"	0.3	1.0	3.1	0.5	6.3	0.3	1.5	0.8	3.3	0.6	0.3	0.1	0.0	0.5	0.4	1.7	0.4	4.6	0.4	0.2	2.7	2.2	0.7	0.2	0.5	0.7	1.1	2.7	0.3	2.6	2.9	2.7	0.9	1.0	0.5	0.4	0.0	0.3	0.4	0.2	0.5	0.4	0.3	0.5	0.3	0.5	65.7	0.7	0.0	0.7	0.1	0.7	0.2	0.0	2.9	0.0	0.2	0.0	1.3	3.7	0.4	8.8	8.6	0.2	7.5	0.0	0.0	0.0	0.0	0.2	0.7	0.7	0.0	2.3	0.0	0.8	0.5	4.9	1.1	1.5	0.0	1.1	8.2	0.9	0.0	1.7	0.0	1.6	0.1	5.7	0.0	3.8	2.3	1.6	1.0	0.3	5.3	0.5	0.2	0.4	12.8	1.6	0.8	1.1	2.3	7.7	0.8	0.0	1.9	3.2	0.0	22.5	6.1	6.4	0.7	0.5	1.5	2.0	1.1	0.1	0.0	0.2	5.0	1.9	2.2	2.8	0.1	3.1	0.3	0.6	0.0	0.0	0.0	3.7	0.0	1.7	2.9	0.7	1.9	0.0	1.5	1.5	1.4	0.2	1.3	0.0	0.0	0.0	0.4	3.1	6.3	0.8	3.3	2.7	2.2	1.1	2.7	1.0	0.7	3.0	0.0	0.0	2.1	0.1	1.4	0.0	0.0	8.1	1.2	5.2	0.0	0.0	8.3	1.7	1715.8	0.1	0.0	0.0	5.3	0.2	0.6	1.0	0.0	0.0	0.1	0.0	8.6	0.6	0.0	4654.0	34.8	0.0	1.7	1.0	0.0	1.0	3.1	0.0	25.8	1.1	0.2	0.0	0.0	89.2	28.0	0.3	0.1	5.0	0.0	0.7
SNRNP35	U1SNRNPBP	ENSG00000184209	"Small nuclear ribonucleoprotein U11/U12 subunit 35"	Q16560	12	123457641-123473154	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059145, HPA067031"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA059145: AB_2683926, HPA067031: AB_2685766"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.56e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-3)"	15.3	15.4	18.7	14.1	20.5	14.1	17.7	25.4	23.1	14.1	15.2	22.8	14.8	14.3	16.0	15.1	17.1	14.8	11.4	22.4	18.5	18.1	16.3	19.3	16.4	16.8	21.2	18.5	13.6	12.9	20.9	19.6	15.6	20.4	16.3	17.1	17.5	21.8	12.9	64.0	24.1	15.0	15.6	20.3	21.0	15.1	14.5	23.6	14.1	20.2	23.7	17.7	12.4	14.2	35.1	24.8	37.5	24.7	23.3	40.4	19.1	12.2	13.1	15.7	8.0	11.5	10.8	13.8	10.7	15.8	11.3	8.3	8.1	8.5	24.3	7.9	15.5	8.2	12.7	13.5	19.2	9.8	17.7	10.9	11.4	11.7	18.5	8.0	11.6	18.3	13.0	13.5	10.1	9.7	20.6	15.4	7.7	14.5	4.9	15.8	25.8	12.5	26.4	11.0	16.5	12.5	9.6	6.9	12.9	25.9	24.8	13.5	19.9	9.5	20.2	14.7	16.4	24.3	15.8	17.8	7.6	13.7	9.5	9.6	12.4	12.4	14.2	12.3	11.4	10.3	37.0	24.4	37.5	24.3	24.7	24.0	35.1	30.8	27.3	24.6	30.7	24.4	25.9	36.7	23.3	22.7	24.8	40.4	19.1	18.7	20.5	25.4	23.1	18.5	18.1	21.2	18.5	20.4	23.6	47.6	19.0	23.0	18.4	12.5	26.4	25.2	20.4	28.1	22.7	31.4	11.8	43.7	43.1	28.8	27.9	20.4	25.4	23.3	29.2	33.0	17.4	16.4	12.7	24.6	28.4	14.3	14.3	25.2	16.2	6.9	22.5	17.5	15.1	45.1	18.2	32.3	29.3	23.0	24.4	33.6	27.7	32.3	11.4	16.1	21.5	12.7	35.1	25.4	15.9	22.7
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891087-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	13.6	3.7	9.3	19.8	8.3	19.0	9.8	9.5	8.4	36.0	48.9	7.1	24.5	10.2	63.4	16.5	14.9	22.9	30.6	24.0	7.5	6.0	29.0	8.8	13.3	16.6	7.0	7.6	16.1	9.4	55.9	8.0	32.4	7.4	18.0	9.8	18.2	8.3	28.1	41.9	5.6	15.1	31.6	7.4	21.2	18.1	15.6	5.4	30.4	26.1	23.1	13.3	27.2	26.8	6.0	4.8	14.0	16.7	6.2	4.3	2.2	5.7	6.6	12.1	13.0	4.3	12.2	10.4	15.8	26.5	14.9	15.3	3.8	18.9	29.7	3.9	10.5	18.9	0.3	9.1	11.4	23.1	2.3	5.2	11.4	4.6	7.9	7.0	21.1	13.1	14.7	2.3	9.2	6.4	12.5	22.9	20.9	13.9	5.1	15.5	4.4	29.3	19.9	6.8	0.9	6.0	26.1	19.7	8.6	12.3	10.7	10.6	9.5	5.8	5.4	6.6	28.6	5.3	16.4	15.6	19.8	22.5	4.9	22.8	12.6	15.5	78.1	8.6	19.4	17.4	1.9	5.0	14.0	2.6	15.6	4.3	4.8	2.6	2.2	4.8	6.0	2.4	3.0	13.9	6.2	16.7	4.2	2.1	2.2	9.3	8.3	9.5	8.4	7.5	6.0	7.0	7.6	7.4	5.4	11.9	7.0	34.9	12.1	7.0	10.8	58.5	20.4	2.7	6.8	26.2	0.0	18.0	64.6	13.4	22.1	27.3	14.6	23.3	34.7	22.8	13.9	30.2	2.3	16.1	28.6	9.5	42.5	20.9	50.5	34.2	21.6	33.1	10.1	36.1	9.0	9.3	33.5	11.9	18.7	55.2	0.9	38.8	93.2	10.3	20.6	7.5	24.4	26.2	9.9	26.3
TBC1D13	FLJ10743	ENSG00000107021	"TBC1 domain family member 13"	Q9NVG8	9	128787204-128810432	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"monocytes: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045865	Approved		Approved	Nucleoli		No	No			Nucleoli		"HPA045865: AB_10965700"	"unprognostic (1.22e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (3.14e-6)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.58e-7)"	"unprognostic (1.72e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	12.5	17.4	23.0	8.3	20.8	12.1	10.1	12.0	24.7	9.8	10.7	17.3	8.4	11.7	13.3	14.2	8.4	14.7	10.9	13.4	17.8	18.5	26.0	8.9	10.5	11.0	13.9	12.7	19.3	11.3	30.2	9.7	9.5	14.9	11.6	8.2	12.5	16.9	14.3	16.6	11.6	13.0	12.6	8.7	12.0	11.2	8.1	13.3	8.6	14.1	7.6	11.2	11.2	8.5	5.0	9.0	15.7	2.8	3.4	5.6	3.4	6.3	15.2	16.0	16.0	20.8	10.1	15.6	15.2	13.1	15.8	10.3	16.5	8.5	10.6	10.6	18.0	15.8	17.2	9.7	12.1	9.4	8.4	11.1	11.4	17.8	15.1	12.9	17.1	23.3	14.1	14.4	13.7	8.3	14.1	20.3	11.4	17.5	7.2	18.8	13.6	10.3	10.2	15.2	17.6	23.0	11.7	14.8	24.1	11.6	8.3	16.2	11.3	21.2	13.6	8.9	16.3	14.5	16.1	16.0	19.9	12.5	16.1	12.3	9.3	11.9	10.5	14.5	10.3	14.2	15.7	2.7	4.6	4.9	2.8	4.9	5.0	3.8	4.7	3.1	4.0	3.3	5.6	2.2	3.4	2.1	9.0	2.8	3.4	23.0	20.8	12.0	24.7	17.8	18.5	13.9	12.7	14.9	13.3	3.0	7.0	4.2	2.6	2.1	8.3	8.9	0.0	4.0	3.4	15.7	9.8	4.3	8.3	5.6	1.3	9.5	7.8	0.0	8.6	4.1	5.7	2.8	8.1	11.6	14.2	6.4	5.2	16.0	8.6	2.3	8.6	4.1	0.0	87.4	6.1	6.7	6.8	7.0	7.1	24.8	5.8	6.5	3.5	5.1	9.3	2.8	2.1	5.0	6.0	2.0
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972037-1982933	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	8.9	7.9	6.0	9.5	8.3	6.0	5.8	16.3	9.6	6.2	6.8	8.8	6.8	7.7	7.1	6.3	9.4	5.4	6.0	7.5	6.6	6.1	7.2	8.7	6.9	7.2	7.0	7.3	7.7	8.9	10.5	5.5	7.3	5.7	5.7	3.6	5.6	10.5	6.0	18.2	9.5	7.8	5.9	4.8	6.7	9.5	20.5	6.5	9.5	7.2	11.5	9.3	5.1	5.4	8.5	11.2	5.8	12.0	14.8	12.1	8.5	5.6	10.9	3.0	5.9	3.0	2.4	9.8	5.2	3.4	4.5	3.7	13.9	10.8	7.5	12.2	3.9	4.1	15.2	4.8	6.0	2.4	5.5	6.9	4.7	5.5	5.2	3.4	8.1	4.5	2.4	4.6	5.6	3.3	3.6	5.6	4.6	9.5	5.5	2.6	9.0	10.3	4.5	7.1	5.0	4.4	18.1	5.5	12.5	2.2	2.1	7.0	5.4	4.7	12.1	4.4	3.1	9.1	5.5	8.7	6.2	7.4	5.5	10.0	10.1	4.4	11.8	3.6	5.2	7.1	4.8	10.2	5.8	12.1	12.0	10.7	7.5	8.9	11.8	11.2	8.5	11.4	8.6	2.5	14.8	11.7	5.7	9.6	8.5	6.0	8.3	16.3	9.6	6.6	6.1	7.0	7.3	5.7	6.5	3.0	9.8	7.5	13.4	11.6	12.1	14.3	7.6	4.0	10.3	17.4	7.9	22.6	6.6	21.3	84.6	9.2	22.2	0.0	19.4	20.7	8.2	12.3	14.9	12.4	17.7	9.5	13.3	8.6	9.7	53.2	13.8	9.8	6.8	29.7	13.7	16.1	19.6	20.1	10.3	13.0	8.7	25.8	9.9	14.4	17.7	15.9	18.8	10.9	15.4	12.4
TENM2	"KIAA1127, ODZ2, Ten-M2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 15.1;heart muscle: 24.7"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 142.6;Horizontal cells: 114.4;Peritubular cells: 58.0"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.7;HBEC3-KT: 17.5;HDLM-2: 17.1;U-138 MG: 31.3;U-2 OS: 27.2;U-251 MG: 20.0"	"Low region specificity"	"Detected in many"							"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No			Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.2	0.4	2.5	0.0	3.5	0.0	1.8	0.5	15.1	0.6	0.3	0.0	0.0	0.3	0.2	0.4	1.4	0.2	0.3	24.7	6.5	0.9	2.7	1.2	0.3	0.0	0.5	1.7	0.7	0.2	0.0	0.4	0.0	2.3	2.2	0.0	0.2	0.3	1.0	0.2	2.3	0.2	0.0	0.6	0.2	0.3	1.2	0.4	0.0	0.4	0.0	0.9	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	0.0	26.7	0.7	0.0	0.0	17.5	0.3	17.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	3.1	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	31.3	27.2	0.0	20.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.5	0.5	15.1	6.5	0.9	0.5	1.7	2.3	0.4	0.0	0.0	0.0	0.7	13.2	9.5	142.6	0.0	0.0	1.2	0.0	17.7	0.0	0.0	2.5	20.1	1.3	0.1	0.0	0.2	0.0	0.7	1.1	1.1	4.2	0.1	114.4	0.0	0.0	0.0	13.2	4.0	0.0	1.7	0.0	0.3	2.1	0.0	0.0	58.0	0.0	1.6	0.0	1.7	0.9	1.1	1.5	0.0	0.0	0.0	0.1
TNFAIP1	"B12, B61, BTBD34, EDP1, MGC2317"	ENSG00000109079	"TNF alpha induced protein 1"	Q13829	17	28335602-28347009	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 88.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013333, HPA014641"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA013333: AB_1858160, HPA014641: AB_1858159"	"unprognostic (4.42e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.32e-2)"	"prognostic unfavorable (7.48e-5)"	"unprognostic (2.29e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.43e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.49e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.02e-2)"	23.1	20.4	17.5	13.3	20.9	5.4	20.7	17.5	32.2	17.2	13.5	17.7	12.6	12.9	17.3	12.1	29.2	12.9	21.1	28.6	14.6	11.4	22.9	69.9	27.8	11.7	15.0	16.5	15.2	30.3	19.5	12.7	43.2	14.2	14.3	12.4	19.2	17.5	15.8	14.8	19.5	16.2	22.1	13.9	40.4	16.8	13.3	14.3	12.5	17.7	18.5	14.7	19.8	15.6	7.2	10.9	11.0	9.6	11.2	10.0	5.8	13.3	19.9	13.1	9.3	11.2	9.9	12.8	16.0	19.7	19.5	15.4	52.4	8.2	3.0	11.1	20.9	9.9	15.7	7.1	27.4	15.1	7.4	9.6	2.4	19.9	7.9	15.1	4.2	4.1	12.8	32.1	15.5	12.1	18.9	22.7	5.8	6.0	4.1	9.1	8.4	7.6	2.7	3.2	12.1	7.0	3.4	16.9	4.7	28.7	14.4	9.7	10.5	20.1	33.7	8.7	19.3	14.1	3.7	24.2	14.6	14.4	11.3	12.2	6.9	5.8	3.0	11.6	3.1	9.3	2.2	8.6	11.0	8.6	8.6	10.0	7.2	6.3	7.6	10.9	5.4	6.2	7.2	2.9	11.2	9.6	5.7	5.4	5.8	17.5	20.9	17.5	32.2	14.6	11.4	15.0	16.5	14.2	14.3	35.7	11.7	6.0	35.7	21.9	22.0	17.3	20.4	13.4	13.6	21.0	15.7	29.0	19.9	56.1	28.8	44.4	10.0	0.0	71.6	29.4	14.3	38.6	6.9	26.4	9.5	11.1	16.7	54.6	12.9	4.2	7.2	6.0	0.0	45.1	9.9	9.5	88.7	12.2	7.4	13.5	9.3	12.9	11.3	3.9	5.5	24.8	57.9	6.5	8.4	39.9
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 21.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.9	2.7	4.2	2.6	2.1	11.7	3.9	4.7	4.7	2.8	7.6	10.9	4.5	5.6	4.8	3.7	8.0	2.2	4.4	1.4	2.8	2.3	6.1	9.5	2.5	2.5	4.3	8.3	3.3	2.3	2.4	2.5	1.9	3.2	7.4	2.9	21.1	2.9	8.1	3.6	10.3	3.2	10.1	3.2	3.4	2.2	5.5	4.7	5.6	2.4	3.2	4.5	10.2	15.7	4.1	6.6	5.7	2.9	3.2	4.7	5.9	3.6	5.5	2.3	2.3	5.2	4.6	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9	8.9	1.0	7.5	2.1	3.5	1.5	3.2	7.6	0.0	1.2	12.2	2.0	2.3	14.9	6.0	16.2	2.9	6.2	23.3	7.6	3.7	3.5	1.2	2.3	12.9	10.5	0.0	0.0	6.2	15.4	1.7	5.8	7.4	33.7	4.6	2.9	2.5	3.7	3.5	6.3	9.6	4.2	6.5	5.9	1.9	3.8	3.0	1.6	2.6	3.4	1.4
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA045161: AB_10960706, HPA073181: AB_2686578"	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.6	5.7	7.0	7.5	12.2	12.5	6.1	9.5	10.5	9.2	9.6	4.7	9.7	4.0	7.9	9.9	14.0	8.8	10.2	9.7	15.3	6.5	6.2	8.1	5.9	7.2	8.2	4.5	11.6	9.8	10.9	10.7	19.2	8.3	11.1	4.5	4.0	8.6	13.9	6.9	9.7	4.8	5.3	12.3	11.2	2.9	7.1	3.4	17.0	9.5	5.2	5.7	7.6	24.7	11.4	7.9	11.5	8.0	9.9	11.1	8.4	8.4	6.9	7.3	7.5	3.0	9.7	7.1	9.5	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3	14.9	12.3	22.7	24.3	49.1	33.4	20.4	20.4	9.4	11.4	50.6	15.7	15.8	43.1	21.3	107.9	29.2	13.4	116.8	15.1	16.5	23.4	29.3	20.7	25.1	35.4	39.7	22.3	20.3	43.6	45.7	19.0	46.1	40.5	76.7	12.2	23.6	17.3	14.0	17.7	41.3	27.1	19.4	60.9	31.4	29.8	56.3	46.1	34.9	12.5	36.9
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.1	7.2	9.6	4.6	3.8	22.1	5.9	3.6	9.1	6.9	11.0	5.8	15.2	6.8	4.1	4.8	10.2	17.8	7.2	8.4	7.4	17.0	9.5	9.3	6.4	4.3	13.8	8.2	3.7	5.3	9.0	7.1	2.3	4.3	9.0	20.0	7.1	5.6	5.8	15.4	6.8	24.2	13.1	7.4	17.3	10.3	15.2	4.1	9.3	10.8	13.3	6.9	7.3	5.8	2.6	8.2	7.9	4.7	7.5	9.5	9.5	16.7	7.9	7.6	22.9	4.0	10.4	13.6	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2	0.0	0.6	1.9	4.7	9.0	6.8	2.4	2.5	0.0	2.3	5.2	27.5	4.2	0.0	2.3	0.3	5.5	0.9	0.0	2.4	8.6	2.7	4.3	0.0	2.9	2.5	3.2	6.3	4.3	1.8	0.8	2.0	2.4	5.0	2.8	1.8	2.7	2.3	0.0	3.2	1.6	17.2	0.0	3.0	5.2	2.9	8.0	2.7	0.0	3.0	3.1
UTP23	"C8orf53, MGC14595"	ENSG00000147679	"UTP23, small subunit processome component"	Q9BRU9	8	116766503-116849463	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044418	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA044418: AB_10961139"	"prognostic unfavorable (5.18e-5)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.23e-2)"	"unprognostic (9.45e-3)"	"unprognostic (7.73e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.34e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.27e-2)"	14.5	11.9	16.9	13.1	21.4	39.5	13.6	25.2	20.0	12.3	12.3	9.3	9.3	8.5	15.6	10.1	11.4	12.9	10.5	11.6	14.4	10.0	9.7	11.6	12.4	18.8	15.4	15.5	20.0	12.7	9.7	15.8	12.8	13.3	13.8	8.3	6.8	11.7	13.4	11.7	11.3	11.5	12.7	13.0	13.2	11.0	8.9	16.2	13.1	16.4	8.7	12.0	13.7	13.7	27.4	23.3	24.2	21.7	16.3	33.3	15.9	10.9	11.9	6.5	5.9	9.3	11.5	4.9	10.8	6.3	7.2	7.9	12.4	7.3	16.2	10.6	5.2	6.8	7.9	8.9	5.8	9.5	16.0	17.3	20.1	9.1	8.2	9.2	10.1	9.6	9.0	7.1	7.1	9.6	5.0	7.7	13.0	13.0	12.4	7.5	20.0	24.5	6.0	5.8	18.0	22.4	13.8	7.0	14.0	4.4	10.1	12.0	9.5	7.0	28.4	9.9	3.7	12.7	7.6	8.6	7.8	10.7	17.9	14.5	15.0	22.8	19.9	9.8	13.1	8.7	24.2	16.3	20.6	26.8	16.8	23.2	27.4	24.4	21.1	14.1	27.3	33.3	23.2	16.2	16.3	21.7	23.3	26.4	15.9	16.9	21.4	25.2	20.0	14.4	10.0	15.4	15.5	13.3	16.2	38.7	31.5	28.3	17.9	19.5	21.6	21.0	10.2	24.1	29.6	7.0	5.9	25.2	23.2	14.5	5.4	22.0	6.9	23.3	18.0	16.2	23.5	11.4	40.5	11.5	14.8	15.9	11.5	25.8	9.1	3.1	26.7	15.6	10.1	15.4	13.7	24.6	10.8	10.5	26.9	13.4	22.2	12.9	18.0	38.8	22.6	14.2	16.6	17.8	14.5	15.5
WDR36	"GLC1G, TA-WDRP, UTP21"	ENSG00000134987	"WD repeat domain 36"	Q8NI36	5	111091716-111130502	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Sensory transduction, Vision"		"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037796, HPA037797"	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA037796: AB_2675673, HPA037797: AB_10672725"	"unprognostic (2.14e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.10e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (4.91e-2)"	30.6	12.3	8.2	15.4	12.2	17.5	15.2	14.5	14.6	15.9	12.2	9.3	10.2	9.6	19.0	11.8	18.4	13.9	11.5	11.7	8.2	9.7	14.8	24.6	12.4	18.7	8.8	11.1	20.6	15.0	14.8	19.1	15.3	13.5	15.0	12.8	9.3	13.6	11.0	17.0	15.2	13.7	14.5	8.9	21.7	12.2	11.3	9.4	24.3	16.7	12.9	18.4	13.8	14.7	6.7	9.9	2.5	10.1	6.0	9.4	6.4	10.1	11.5	8.1	21.1	12.7	17.8	13.5	8.6	8.8	12.9	19.1	13.3	12.1	30.6	11.2	6.9	16.6	11.2	16.6	20.0	22.6	10.9	9.2	16.8	11.3	10.3	13.3	15.3	30.9	10.2	11.0	22.6	22.6	19.5	15.0	12.1	20.1	15.6	13.8	8.5	20.1	11.7	10.4	9.0	10.2	16.5	18.8	23.8	8.9	13.4	14.4	10.9	11.5	8.3	12.6	9.6	9.6	10.3	10.5	16.8	11.1	12.4	17.7	12.7	11.8	33.0	12.9	20.5	13.5	0.2	6.4	2.5	7.8	8.6	9.2	6.7	6.7	8.7	9.9	5.9	9.4	7.8	0.4	6.0	10.1	4.3	9.0	6.4	8.2	12.2	14.5	14.6	8.2	9.7	8.8	11.1	13.5	9.4	17.9	14.4	16.0	8.0	54.3	8.4	13.3	17.8	14.7	25.0	15.7	5.9	8.0	6.6	9.3	5.0	17.3	5.2	0.0	11.7	8.0	12.8	8.7	13.9	27.2	12.8	11.1	5.8	15.4	17.7	2.6	8.1	12.6	20.3	16.2	13.4	5.6	7.9	7.0	10.6	9.8	8.3	19.4	11.3	16.9	14.5	50.6	4.5	9.6	11.5	8.8
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal glandular cells: 165.0;Suprabasal keratinocytes: 167.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli		No	No			Nucleoli		"CAB004619: AB_628447, HPA068845: AB_2686048"	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.4	5.6	21.5	11.9	18.9	9.5	42.6	17.9	13.8	10.0	10.0	10.2	17.8	33.9	6.7	7.8	9.4	17.5	14.7	6.9	12.8	12.1	12.0	13.3	9.0	6.8	2.0	20.1	13.3	3.1	7.5	4.7	16.6	10.4	6.2	13.2	21.6	23.6	17.4	3.4	20.5	10.9	32.4	10.0	6.4	19.8	16.9	7.3	7.9	30.5	8.1	10.6	12.1	14.3	8.7	26.8	9.0	9.6	7.1	18.1	12.6	7.3	14.2	5.5	16.5	44.8	7.7	11.1	12.6	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0	47.6	26.9	13.5	165.0	156.6	1.8	53.3	66.2	49.5	56.9	40.1	0.0	78.4	11.6	22.0	18.2	13.0	34.2	23.3	11.8	154.6	38.6	75.9	6.9	86.3	14.7	1.6	58.5	9.2	1.6	29.5	10.9	8.4	16.9	2.8	32.0	9.3	20.6	25.7	10.3	6.7	4.4	6.5	22.1	42.6	52.9	167.1	114.8	13.1	37.4	55.3
ZNF136	pHZ-20	ENSG00000196646	"Zinc finger protein 136"	P52737	19	12163064-12189881	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA054120			Approved	Nucleoli		NA	NA			Nucleoli		"HPA054120: AB_2682389"	"unprognostic (1.40e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.46e-3)"	"prognostic favorable (4.75e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-2)"	12.6	10.8	7.2	15.3	11.0	20.5	13.0	19.6	12.4	13.2	9.5	7.1	10.5	4.5	13.3	13.0	5.9	11.6	8.2	8.0	7.3	7.2	9.4	6.0	11.1	12.7	7.5	11.3	19.0	7.5	13.0	16.8	10.6	10.2	13.0	8.6	8.3	10.1	8.9	9.9	10.4	9.4	12.9	12.5	11.7	10.0	10.2	6.8	16.0	14.4	3.6	10.7	12.6	11.3	9.7	5.1	13.5	4.1	8.7	10.0	4.0	2.1	1.2	7.4	7.7	4.1	4.7	4.5	4.0	4.4	3.9	4.1	1.4	0.7	10.1	5.3	2.9	3.7	2.2	3.5	2.4	5.0	5.0	4.6	5.7	3.7	2.5	3.1	12.1	10.3	5.0	4.4	3.7	4.6	5.7	2.8	8.6	4.2	16.3	4.9	3.0	8.3	4.8	8.7	0.7	4.5	6.6	9.4	3.9	4.2	7.7	7.7	7.2	5.1	1.2	4.2	6.4	3.2	6.3	5.7	9.7	3.3	4.0	3.5	11.1	19.2	11.5	3.6	4.6	5.0	13.5	3.9	9.0	7.9	3.7	9.4	9.0	8.9	8.5	4.2	9.7	10.0	8.4	11.6	8.7	4.1	5.1	5.9	4.0	7.2	11.0	19.6	12.4	7.3	7.2	7.5	11.3	10.2	6.8	6.0	6.5	14.5	9.8	4.8	18.5	2.4	12.7	2.7	11.4	8.7	17.7	6.5	5.0	5.4	1.7	6.9	3.9	23.3	3.4	5.8	7.7	7.8	8.1	2.4	4.9	19.1	9.8	8.6	5.3	0.9	12.4	6.9	1.7	10.8	5.3	12.8	4.2	5.1	13.8	3.4	15.2	6.5	11.3	19.4	28.6	2.8	8.2	10.0	4.3	9.8
ZNF146	OZF	ENSG00000167635	"Zinc finger protein 146"	Q15072	19	36214602-36238774	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003358	Supported		Supported	Nucleoli		NA	NA			Nucleoli		"HPA003358: AB_1080674"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.11e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.92e-1)"	20.6	17.2	24.5	23.5	40.4	8.6	33.0	25.7	27.9	28.9	20.7	28.4	23.5	17.9	30.0	18.2	22.3	23.0	18.0	21.5	25.6	20.0	21.1	25.0	18.1	25.0	46.4	23.7	33.7	20.3	32.5	45.2	25.1	32.0	25.2	25.5	13.4	19.6	23.9	38.3	21.1	17.7	26.2	30.9	19.9	19.2	9.9	36.3	33.6	27.1	24.0	28.3	25.8	20.5	13.7	9.8	5.9	14.6	10.2	18.3	10.3	21.7	30.4	26.1	25.0	19.3	21.7	13.9	19.3	17.9	18.7	18.6	13.7	16.0	21.2	31.2	17.8	12.2	10.2	33.0	22.5	33.9	32.8	18.4	35.5	11.7	16.5	22.5	55.7	24.6	17.6	35.0	18.0	51.4	19.7	23.1	23.2	37.6	23.4	22.4	14.2	25.8	13.2	35.2	38.4	18.6	30.0	26.2	18.1	22.7	21.5	33.1	20.9	23.8	30.2	20.4	28.0	13.4	28.6	17.5	21.1	25.3	16.5	33.7	16.4	19.3	30.3	14.8	27.7	26.8	4.9	8.2	5.9	12.2	9.9	17.4	13.7	14.1	12.2	9.8	12.1	18.3	16.6	2.0	10.2	14.6	4.9	12.1	10.3	24.5	40.4	25.7	27.9	25.6	20.0	46.4	23.7	32.0	36.3	41.7	25.3	20.4	25.2	20.9	10.1	40.2	22.9	30.8	33.0	19.2	9.8	29.2	29.9	24.6	14.9	20.6	8.5	0.0	15.6	40.2	22.4	23.6	19.7	17.3	16.6	11.1	13.9	20.3	18.6	13.5	23.3	13.5	10.1	10.0	23.8	9.1	20.1	5.8	18.0	16.5	9.4	6.5	35.3	7.7	12.4	26.1	19.7	21.8	24.5	24.3
ZNF275		ENSG00000063587	"Zinc finger protein 275"	Q9NSD4	X	153334155-153360110	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 38.6"	"Cell type enhanced"	"Detected in many"	7	"Hepatocytes: 25.5;Peritubular cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 36.2;U-698: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000566	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA000566: AB_1080700"	"unprognostic (6.96e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.59e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.33e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.14e-2)"	6.5	38.6	5.9	3.4	5.9	2.2	11.5	5.9	6.9	5.8	3.5	7.0	20.4	2.8	5.9	12.6	2.5	5.4	4.9	3.0	6.8	6.9	3.8	8.5	3.3	7.0	8.8	5.3	30.3	8.5	5.8	6.9	2.1	6.2	5.1	3.2	3.8	6.3	27.9	3.1	2.5	4.5	5.6	10.7	6.8	4.1	10.5	6.5	3.9	4.7	1.7	5.3	4.0	2.6	4.5	2.7	0.7	1.7	2.8	5.0	2.0	6.0	2.7	5.3	3.7	6.1	6.0	2.6	4.2	7.0	2.7	4.1	2.8	1.4	10.4	8.7	7.9	4.0	1.0	6.0	3.8	4.0	2.4	4.8	3.3	2.6	3.9	8.2	4.2	3.1	7.1	2.7	2.3	4.3	4.4	3.3	5.7	5.1	0.0	4.8	4.4	4.9	3.5	2.4	5.9	4.3	6.0	5.6	3.6	2.0	4.0	2.7	3.7	2.1	0.2	5.1	3.4	1.0	7.5	3.5	4.1	4.9	6.8	5.4	36.2	9.6	20.7	3.7	8.5	2.8	0.7	1.7	0.2	3.7	1.5	4.4	4.5	3.4	3.3	1.6	4.4	5.0	4.2	0.1	2.8	1.4	2.7	4.6	2.0	5.9	5.9	5.9	6.5	6.8	6.9	8.8	5.3	6.2	6.5	0.0	5.8	5.2	3.4	3.0	6.6	4.7	10.2	1.4	2.3	8.7	11.8	1.3	6.6	2.6	1.2	4.1	1.6	0.0	4.4	3.4	7.2	4.9	2.3	25.5	2.2	0.0	0.0	8.0	5.3	2.0	13.3	3.1	3.3	1.0	6.2	6.3	4.4	2.9	37.1	6.5	2.2	12.9	11.4	3.3	3.4	1.9	0.7	3.8	5.0	1.7
ZNF286A	"KIAA1874, ZNF286"	ENSG00000187607	"Zinc finger protein 286A"	Q9HBT8	17	15699577-15720787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SuSa: 49.4"									HPA021594			Approved	Nucleoli		No	No			Nucleoli		"HPA021594: AB_2670768"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.47e-4)"	"unprognostic (4.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.94e-2)"	3.7	5.9	6.6	5.5	9.5	2.0	6.0	8.2	7.8	9.7	5.3	6.5	10.0	2.5	11.3	10.0	7.6	6.6	6.6	11.5	7.6	6.5	6.1	3.2	3.5	7.0	8.7	4.7	14.3	2.9	9.8	15.9	4.0	9.4	7.1	3.5	7.1	4.7	8.3	3.8	4.0	3.5	8.4	10.7	4.5	3.4	14.2	9.0	5.2	8.0	3.8	6.0	6.9	6.0	6.4	2.7	1.0	3.6	6.0	9.8	2.5	13.4	15.2	22.2	10.7	6.5	9.4	7.1	6.3	5.5	10.5	8.4	9.1	4.8	12.0	5.2	5.3	9.0	11.9	15.7	7.4	13.1	8.8	12.2	8.2	15.6	7.8	6.4	4.0	4.0	8.8	4.7	9.9	10.0	12.2	13.8	20.2	7.1	2.4	14.7	3.7	17.6	3.7	20.5	8.0	3.6	13.2	32.3	5.9	7.6	5.2	7.0	15.9	13.7	5.9	4.8	49.4	5.5	2.4	6.1	6.6	7.0	5.7	9.5	5.3	8.3	0.0	8.0	0.1	7.3	0.8	1.6	1.0	6.9	1.9	7.1	4.0	7.9	7.0	2.5	6.4	9.2	9.8	1.0	6.0	3.6	2.7	9.5	2.5	6.6	9.5	8.2	7.8	7.6	6.5	8.7	4.7	9.4	9.0	17.9	0.0	4.9	4.1	6.3	2.1	3.6	2.5	2.7	6.8	1.8	2.0	1.2	1.7	3.4	10.2	3.0	0.2	0.0	1.4	1.5	3.3	2.9	3.5	0.5	1.1	3.2	5.2	1.8	0.6	8.2	4.6	1.1	1.7	1.0	2.0	1.3	3.4	0.8	4.9	2.1	1.6	0.0	3.5	10.5	5.4	4.8	1.0	2.5	1.2	4.1
ZNF330	"HSA6591, NOA36"	ENSG00000109445	"Zinc finger protein 330"	Q9Y3S2	4	141220887-141234697	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 80.7"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 163.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015705, HPA056325"	Uncertain		Supported	Nucleoli		NA	NA			Nucleoli		"HPA015705: AB_1859199, HPA056325: AB_2683101"	"unprognostic (1.90e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (3.66e-6)"	"prognostic favorable (7.27e-6)"	"unprognostic (3.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.30e-2)"	21.7	15.9	8.9	12.2	13.7	16.2	13.8	17.5	11.2	14.9	17.4	9.8	14.2	9.5	19.0	15.6	13.6	14.0	10.5	80.7	9.0	9.5	14.9	26.7	15.2	13.4	13.7	8.6	14.9	16.5	13.2	15.1	10.4	12.7	12.2	12.3	22.3	44.9	11.4	34.7	10.9	12.6	18.9	14.1	16.0	14.2	14.2	13.3	14.3	23.5	15.4	13.5	18.7	16.0	16.3	21.9	12.2	20.8	14.6	19.3	11.8	7.7	9.6	11.6	9.2	20.9	18.9	16.4	21.0	12.1	13.5	12.8	12.9	15.0	33.4	12.9	13.2	7.6	6.3	20.5	13.6	20.8	15.4	13.4	15.5	14.8	18.1	22.4	38.9	12.5	18.9	16.0	12.7	18.6	16.5	14.1	20.7	31.4	22.8	17.2	17.6	30.1	18.3	10.3	24.1	18.3	24.6	16.7	21.1	14.5	8.7	20.3	9.4	7.3	16.9	20.6	13.7	8.4	10.7	15.0	17.3	11.7	10.4	14.9	38.2	27.4	31.7	14.5	24.4	12.3	9.7	20.8	12.2	12.9	17.5	17.8	16.3	16.4	16.6	21.9	13.4	18.0	16.2	3.2	14.6	13.5	15.0	19.3	11.8	8.9	13.7	17.5	11.2	9.0	9.5	13.7	8.6	12.7	13.3	50.6	29.6	27.4	41.1	43.7	64.5	140.4	22.9	20.1	23.9	8.7	13.7	30.9	49.7	27.5	163.4	28.7	21.1	23.3	44.0	30.7	29.8	28.9	23.0	63.5	61.1	15.9	16.1	33.7	48.2	40.5	36.2	41.2	43.9	17.2	22.7	29.8	35.0	24.6	26.9	67.2	23.1	12.9	36.8	47.3	16.1	45.0	28.7	24.9	26.0	54.1
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 44.0;Horizontal cells: 33.4;Muller glia cells: 21.7;Rod photoreceptor cells: 22.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli		NA	NA			Nucleoli		"HPA055041: AB_2682681"	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.2	4.8	0.4	0.6	1.0	0.4	1.6	3.2	3.0	0.4	1.5	0.5	0.5	1.3	2.4	0.9	1.5	1.7	1.9	0.2	1.9	1.7	4.5	2.6	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.4	2.9	2.1	1.3	0.9	0.7	3.0	0.2	0.8	11.8	1.5	1.1	0.3	4.9	0.4	1.2	1.3	6.9	3.3	1.2	0.6	0.8	3.0	1.9	0.4	0.5	1.0	1.6	1.5	2.2	0.7	1.9	0.4	1.1	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3	0.0	7.5	0.0	4.4	0.7	44.0	2.9	0.0	1.4	6.8	7.0	19.6	0.9	5.0	0.8	17.5	1.8	0.2	0.0	1.8	0.5	3.1	3.3	0.0	2.1	0.3	33.4	2.9	0.6	0.0	6.7	4.4	1.0	1.7	0.0	0.0	21.7	0.9	0.0	9.6	0.0	22.6	6.5	2.3	7.5	2.7	1.3	0.6	0.0	0.1	3.0
ZNF519	"FLJ36809, HsT2362"	ENSG00000175322	"Zinc finger protein 519"	Q8TB69	18	14057457-14132490	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 14.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA028982	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA028982: AB_10610705"	"unprognostic (1.85e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.65e-4)"	1.8	1.4	2.8	1.9	7.6	1.4	2.8	13.7	14.4	5.7	4.6	0.7	0.8	1.2	7.0	2.6	3.4	4.5	1.8	1.9	3.4	1.6	0.8	1.0	2.7	6.6	1.7	4.0	8.7	1.2	1.1	1.5	1.2	3.0	2.6	2.6	2.0	1.6	2.7	1.0	2.0	2.1	6.0	2.1	2.2	1.4	3.0	2.5	1.1	2.0	0.9	1.9	4.3	3.8	1.7	0.1	0.0	0.6	0.5	3.5	0.7	1.3	0.3	6.0	6.3	0.8	1.2	1.6	1.6	0.9	3.5	3.2	2.7	1.2	3.1	1.7	1.2	1.6	1.0	4.9	1.2	4.1	1.9	3.3	5.5	1.8	1.1	0.2	11.3	2.4	0.6	1.6	2.9	1.2	1.0	0.6	4.7	2.7	4.7	2.0	1.8	6.9	4.4	2.7	3.5	1.4	7.4	5.8	3.9	0.9	1.9	9.3	2.5	2.3	0.8	1.8	4.0	0.7	3.1	0.4	5.7	7.6	2.5	1.8	1.8	1.2	4.5	1.8	4.4	4.7	0.0	0.3	0.0	1.1	0.6	1.8	1.7	1.4	1.5	0.1	0.8	3.5	2.2	0.0	0.5	0.5	0.1	2.0	0.7	2.8	7.6	13.7	14.4	3.4	1.6	1.7	4.0	3.0	2.5	6.0	7.4	4.2	2.4	1.8	14.4	4.4	2.5	2.7	1.2	0.0	2.0	2.3	1.7	2.0	0.7	2.1	0.1	0.0	1.7	3.5	3.9	1.2	3.5	0.8	1.5	3.2	1.2	3.7	2.4	1.1	6.1	1.8	1.7	1.0	1.3	5.0	0.8	0.0	8.5	0.6	6.8	0.0	2.2	6.9	11.5	1.1	0.7	4.4	2.5	1.4
ZNF57	ZNF424	ENSG00000171970	"Zinc finger protein 57"	Q68EA5	19	2900898-2918476	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 74.9;Late spermatids: 28.7;Suprabasal keratinocytes: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA061915			Approved	Nucleoli		NA	NA			Nucleoli		"HPA061915: AB_2684635"	"unprognostic (3.59e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.91e-2)"	"unprognostic (8.86e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.07e-2)"	"unprognostic (7.66e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.04e-2)"	"prognostic favorable (7.72e-4)"	"unprognostic (2.34e-3)"	"prognostic favorable (4.11e-9)"	"unprognostic (6.26e-3)"	"unprognostic (2.82e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.49e-3)"	3.6	2.9	3.6	3.2	4.7	4.0	7.3	17.2	5.7	6.2	15.7	2.3	5.1	7.8	5.6	4.2	11.0	4.7	4.0	4.2	3.3	2.7	9.2	3.9	4.9	2.9	2.6	3.2	5.4	7.4	3.9	4.1	5.8	4.2	6.1	10.1	3.6	5.5	8.7	7.4	18.6	18.5	2.1	2.4	3.6	11.7	26.4	3.9	2.9	5.4	7.0	6.6	5.0	7.9	4.9	3.6	1.4	5.8	6.3	8.4	4.1	6.7	3.2	4.4	6.4	4.3	3.7	7.4	2.9	2.3	4.6	4.8	6.5	2.6	5.7	3.7	2.3	6.7	7.9	7.0	9.9	5.8	0.0	3.6	3.3	3.7	8.6	3.3	0.0	6.3	2.9	11.1	4.1	8.8	3.8	3.5	13.8	5.8	0.1	3.6	6.8	8.6	3.7	2.9	8.0	5.6	8.0	13.5	1.3	6.3	11.1	2.2	3.3	4.2	7.9	2.7	6.5	4.9	5.5	2.7	3.2	3.1	7.3	4.0	1.2	6.5	2.8	2.6	0.9	2.5	0.0	3.3	1.4	6.5	5.8	5.4	4.9	7.1	6.7	3.6	4.9	8.4	7.4	1.2	6.3	3.1	3.4	7.1	4.1	3.6	4.7	17.2	5.7	3.3	2.7	2.6	3.2	4.2	3.9	0.0	4.0	0.0	17.8	19.1	1.9	2.5	2.5	4.0	10.3	0.0	5.9	3.6	3.3	2.8	74.9	1.4	11.8	0.0	2.0	3.4	2.5	3.4	0.0	1.6	1.9	1.6	0.0	1.8	1.0	28.7	2.3	1.9	5.0	1.8	5.0	1.6	1.4	7.0	2.8	2.4	2.6	0.0	3.9	4.1	11.5	25.1	5.5	0.0	6.0	8.9
ZNF713	FLJ39963	ENSG00000178665	"Zinc finger protein 713"	Q8N859	7	55887475-55942225	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 13.4;Early spermatids: 14.3;Late spermatids: 12.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 10.2"					"Low region specificity"	"Detected in all"			"HPA059425, HPA062887"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA059425: AB_2684013, HPA062887: AB_2684894"	"unprognostic (5.27e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.07e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.78e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-3)"	2.0	2.7	7.0	2.6	9.7	4.1	4.0	5.6	9.3	3.8	2.2	10.6	2.7	2.7	5.5	3.5	1.7	7.1	2.9	2.4	7.8	6.1	3.9	1.7	2.6	1.7	13.4	4.8	5.6	3.2	4.2	8.1	2.2	7.3	4.1	1.9	2.6	2.4	2.9	4.7	3.1	1.9	3.7	9.8	2.5	4.0	9.4	10.6	6.9	4.9	0.4	1.8	2.1	2.0	2.2	1.7	6.9	1.3	1.4	1.0	0.4	1.8	1.2	7.4	6.7	0.9	1.0	2.6	0.8	0.5	1.0	1.4	0.7	2.4	3.1	2.7	0.6	2.1	0.7	1.8	0.6	1.4	1.7	2.9	0.7	2.5	1.9	1.2	3.7	2.0	1.7	1.5	0.5	1.4	1.7	1.8	3.4	2.0	1.4	1.2	1.6	3.7	2.2	5.0	1.9	1.4	3.1	1.8	0.4	3.6	3.3	8.6	10.2	4.3	1.2	1.2	4.1	2.8	3.3	1.9	0.9	3.6	0.7	1.2	1.6	2.2	1.4	0.6	2.1	6.3	3.7	1.3	3.3	0.9	1.0	0.6	1.3	0.7	0.6	0.4	2.2	0.9	1.0	6.9	1.4	1.0	1.7	0.4	0.4	7.0	9.7	5.6	9.3	7.8	6.1	13.4	4.8	7.3	10.6	0.0	3.0	0.0	2.8	1.1	2.8	1.5	5.1	13.4	4.5	0.0	9.8	1.0	0.0	1.0	14.3	1.4	0.3	0.0	1.2	1.0	1.4	1.6	1.1	0.0	0.4	7.9	0.0	1.3	2.1	12.1	0.6	1.8	0.0	0.0	1.0	5.8	1.3	0.0	2.5	0.5	2.7	6.5	1.4	6.0	6.1	1.6	1.7	1.3	0.9	2.2
ZNF790	"FLJ20350, MGC62100"	ENSG00000197863	"Zinc finger protein 790"	Q6PG37	19	36817428-36850787	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA056134, HPA060288"	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA056134: AB_2683049, HPA060288: AB_2797260"	"unprognostic (1.14e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.48e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-2)"	6.6	8.9	9.3	9.9	15.9	3.2	7.2	21.5	14.8	7.6	6.4	12.5	7.1	6.4	7.7	7.7	7.5	6.1	8.1	8.8	10.8	7.9	10.3	13.8	6.1	7.9	14.2	7.2	7.8	7.3	11.6	14.5	6.0	13.1	6.8	4.5	7.4	5.7	7.3	7.3	15.6	6.1	6.1	11.4	7.4	7.9	20.4	15.9	8.5	13.2	4.9	6.8	7.7	7.9	9.7	6.8	6.8	6.2	6.7	9.0	3.0	0.0	0.7	6.4	11.6	4.5	4.8	4.1	4.5	6.1	3.6	6.5	0.0	1.4	1.4	9.1	3.3	4.5	1.7	5.0	4.1	3.3	10.4	4.5	7.4	0.7	1.7	3.8	3.3	5.6	6.1	3.4	3.1	0.0	4.3	6.1	5.8	0.2	0.1	8.0	3.5	8.4	2.6	4.3	0.0	0.8	1.5	5.3	5.6	3.9	8.4	8.0	7.3	4.2	0.1	2.5	7.6	5.2	6.2	6.7	5.0	3.8	4.5	5.9	9.1	12.7	5.2	0.0	0.2	4.0	6.0	3.7	6.8	5.9	6.2	6.1	9.0	8.4	8.3	6.8	9.7	9.0	7.4	1.3	6.7	2.2	5.6	6.8	3.0	9.3	15.9	21.5	14.8	10.8	7.9	14.2	7.2	13.1	15.9	3.0	0.6	5.9	3.0	1.5	23.7	3.4	7.6	1.4	1.2	7.0	29.5	5.5	5.0	4.1	72.8	6.6	5.1	0.0	4.5	3.0	3.3	3.0	4.6	5.5	3.7	11.1	2.4	5.5	3.7	24.9	7.8	3.2	3.3	4.6	2.7	10.1	3.8	3.1	4.6	8.1	25.0	0.0	5.0	5.6	1.6	3.6	4.9	7.5	2.3	7.2
ZNF837		ENSG00000152475	"Zinc finger protein 837"	Q96EG3	19	58367618-58381060	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.4"									HPA042833	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA042833: AB_10806373"	"unprognostic (2.61e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.33e-1)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.07e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.75e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.02e-2)"	"prognostic favorable (1.76e-5)"	"unprognostic (2.35e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.07e-2)"	3.7	3.3	4.2	2.2	5.4	1.1	2.3	1.0	6.1	3.1	2.5	2.9	1.2	4.6	3.6	4.4	3.1	5.2	3.0	1.4	2.0	1.7	5.3	10.8	3.7	2.1	1.6	0.9	4.3	5.1	2.7	4.1	3.7	2.1	3.8	1.0	2.9	4.6	2.5	1.3	5.7	6.1	1.1	1.4	4.7	4.9	2.6	1.2	9.4	7.1	1.3	5.1	2.3	2.2	0.9	0.5	0.1	0.3	0.0	1.7	0.4	2.0	1.0	1.3	1.5	0.2	0.5	2.3	2.0	0.4	0.1	0.2	0.5	2.1	2.5	1.8	0.0	0.8	0.6	0.1	0.1	0.1	1.3	13.4	1.1	0.3	0.1	0.5	0.8	0.7	0.8	0.4	0.2	0.1	0.5	0.2	3.2	1.5	0.7	0.2	2.7	5.8	2.3	3.5	0.8	3.4	5.0	0.6	2.4	0.3	1.5	4.0	5.2	1.5	1.3	2.3	0.2	1.6	1.1	0.5	3.0	0.1	0.8	0.7	3.2	2.4	2.2	1.9	0.4	0.8	0.0	0.3	0.0	1.3	0.0	1.4	0.5	1.6	0.0	0.4	0.9	1.7	0.2	0.1	0.0	0.0	0.5	0.7	0.4	4.2	5.4	1.0	6.1	2.0	1.7	1.6	0.9	2.1	1.2	3.0	2.6	5.2	0.8	0.8	1.3	1.3	0.0	0.0	1.2	3.5	0.0	1.5	6.6	3.7	3.7	1.0	2.6	0.0	4.6	0.9	0.8	1.8	0.0	3.4	0.9	1.6	1.2	2.5	0.3	0.4	1.7	0.1	3.3	4.6	2.6	2.0	2.5	3.1	1.1	4.4	0.5	0.0	1.9	2.1	5.9	1.5	1.8	0.8	2.1	0.9
ZNF853	DKFZp434J1015	ENSG00000236609	"Zinc finger protein 853"	P0CG23	7	6615617-6624290	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 13.0;Muller glia cells: 10.9;Rod photoreceptor cells: 9.1;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 3.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.1;NK-cells: 1.1;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.8;SH-SY5Y: 22.1;U-2 OS: 14.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067690	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA067690: AB_2685888"	"unprognostic (1.35e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.17e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.87e-3)"	"unprognostic (9.28e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.30e-3)"	"unprognostic (4.01e-2)"	3.7	3.9	16.6	2.9	14.4	1.0	4.6	4.5	13.5	7.8	7.7	10.4	2.8	1.8	9.4	5.9	5.6	11.8	5.8	12.3	16.1	15.5	3.3	0.9	4.5	4.3	14.8	9.1	15.6	10.6	7.3	4.5	3.7	11.9	7.6	2.5	6.0	6.7	11.5	28.9	2.4	2.7	8.5	10.1	4.3	3.6	3.0	9.9	2.6	9.9	2.7	2.7	6.5	11.7	0.3	0.4	3.1	0.0	1.1	1.5	0.3	0.0	1.2	3.5	14.8	0.1	0.0	0.1	0.3	0.0	1.6	0.3	2.6	0.6	0.0	5.8	0.0	0.5	0.0	5.3	0.1	1.5	0.0	1.9	0.4	0.0	2.7	2.1	0.0	0.1	0.5	0.5	0.2	0.0	1.5	0.0	1.2	2.2	0.0	0.9	0.1	0.3	1.9	5.5	0.0	0.0	1.6	5.8	0.1	1.1	5.5	4.7	22.1	0.0	0.2	0.9	3.0	0.8	3.1	0.0	1.1	14.8	0.0	1.3	0.3	0.1	0.0	0.0	0.0	5.7	0.0	0.0	3.1	1.2	0.0	1.5	0.3	0.8	1.4	0.0	0.3	0.2	1.4	0.0	1.1	0.0	0.4	0.0	0.3	16.6	14.4	4.5	12.4	16.1	15.5	14.8	9.1	11.9	9.9	0.0	0.0	0.0	1.5	0.5	13.0	8.5	0.0	4.0	1.2	7.0	5.9	0.0	0.0	0.5	1.5	1.5	0.0	0.0	0.6	0.0	2.3	1.1	0.0	0.0	0.1	4.8	1.7	1.8	0.0	1.7	4.9	0.0	3.3	0.0	0.0	10.9	0.4	0.0	8.1	0.2	9.1	12.9	1.4	0.5	0.7	0.3	0.2	0.8	0.0	0.7
ZSCAN1	"FLJ33779, ZNF915"	ENSG00000152467	"Zinc finger and SCAN domain containing 1"	Q8NBB4	19	58034032-58054631	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.7;epididymis: 16.4;pituitary gland: 15.8"	"Group enriched"	"Detected in some"	4	"Distal tubular cells: 10.0;Early spermatids: 20.0;Late spermatids: 14.4;Muller glia cells: 5.8;Spermatocytes: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HMC-1: 4.4;NTERA-2: 4.5;T-47d: 6.5"									HPA007938	Uncertain		Approved	Nucleoli		NA	NA			Nucleoli		"HPA007938: AB_1080768"	"unprognostic (1.60e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (1.41e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.47e-2)"	"unprognostic (3.60e-1)"	0.9	2.2	7.0	0.7	9.5	0.9	3.2	4.0	13.7	2.2	0.8	6.5	1.0	0.8	1.7	16.4	0.8	4.3	1.3	1.6	6.3	9.7	2.8	0.7	1.4	0.8	6.0	6.7	0.9	2.1	7.3	15.8	1.3	8.2	3.7	0.7	3.4	1.6	3.0	0.8	0.8	1.0	1.1	3.7	0.9	1.0	13.3	2.4	0.9	8.1	0.0	0.7	1.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	0.0	1.6	0.1	0.0	0.0	0.0	6.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	1.3	0.0	0.0	0.0	0.9	6.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	9.5	4.0	13.7	6.3	9.7	6.0	6.7	8.2	2.4	0.0	0.0	0.0	0.3	0.0	2.8	0.6	0.0	0.0	0.0	1.8	2.0	0.0	10.0	0.8	20.0	0.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	14.4	0.9	0.0	1.7	0.0	0.0	5.8	0.4	0.0	0.0	0.0	2.1	0.0	0.3	17.0	3.1	0.0	0.0	0.0	0.0	0.4
ZXDC	"FLJ13861, MGC11349"	ENSG00000070476	"ZXD family zinc finger C"	Q2QGD7	3	126437601-126475919	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049593			Approved	Nucleoli		Yes	No			Nucleoli		"HPA049593: AB_2680828"	"unprognostic (3.06e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.06e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.12e-3)"	13.4	9.7	11.5	8.5	13.1	44.5	12.6	15.9	11.7	12.1	10.6	16.0	12.3	6.9	14.4	12.0	11.9	12.3	10.3	8.5	10.5	5.7	10.2	14.9	10.6	9.9	17.4	7.9	15.7	19.3	19.2	11.9	9.9	10.9	12.4	7.6	13.4	13.2	9.7	28.9	18.0	10.2	10.0	10.5	11.0	9.8	9.0	13.2	14.1	11.6	8.5	9.1	14.5	12.3	1.0	2.2	2.5	7.6	0.8	1.1	0.4	14.1	7.3	9.2	8.6	10.0	7.9	16.3	6.5	7.2	9.5	8.5	10.9	6.2	10.6	11.0	5.8	8.8	11.7	12.2	7.5	7.5	5.6	10.3	8.2	8.4	7.1	10.7	12.6	13.5	6.2	14.7	5.8	10.5	9.4	9.6	12.6	8.8	14.2	7.9	8.3	12.1	7.0	13.0	9.3	7.4	13.1	6.2	13.3	6.7	10.3	16.7	9.3	12.4	9.2	17.1	6.3	12.4	11.2	9.7	8.8	11.4	13.1	7.8	11.8	5.5	14.0	9.6	9.9	9.6	2.4	0.8	1.6	1.1	0.4	0.4	0.3	0.8	0.8	1.4	1.0	1.1	1.0	2.5	0.8	7.6	2.2	0.5	0.4	11.5	13.1	15.9	11.7	10.5	5.7	17.4	7.9	10.9	13.2	23.8	14.1	2.7	7.3	5.6	28.6	3.4	15.3	6.7	9.1	5.2	43.2	6.2	6.6	4.4	1.5	6.8	7.7	0.0	5.2	2.0	3.8	5.0	2.3	11.3	5.1	12.7	3.5	7.4	4.3	0.2	6.9	6.2	1.7	1.8	5.9	24.0	4.0	4.9	7.1	6.9	27.2	0.0	4.7	3.2	7.7	3.8	5.3	5.0	6.3	5.3